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Abstract 
Stroke outcome is highly variable.  Experiments in this thesis test the 
hypothesis that experience prior to a stroke is an important variable in the 
manifestation of stroke.  Optokinetic tracking was used to evaluate the effects of 
visual cortex stroke and MCA occlusion in rats.  Normal laboratory rats showed a 
small, but significant decrease in tracking thresholds following visual cortex 
stroke.  Animals with developmental visuomotor experience or reach training 
experience in adulthood, however, had tracking thresholds which were 
substantially increased, and the effects of visual cortex strokes were greater. MCA 
occlusions did not affect tracking behaviour.  These data indicate that specific 
experiences engage neural plasticity that can alter brain function.  These changes 
can, in turn, affect the behavioural manifestation of a stroke.  Understanding the 
effect that environmental experience has on stroke outcome promises to enable 
better characterization of strokes, and set appropriate behavioural baselines for the 
measurement of recovery of function. 
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Chapter 1 - Introduction 
Imagine you are on vacation at your favorite hot spot.  You wake up in the 
morning, get your cup of coffee, and sit out on the patio to enjoy the view.  After 
a few minutes you get up to refresh your cup and stumble a bit, but think nothing 
of it as it is still early in the day and you haven’t done much moving around.  
Soon you start to develop a headache, and you hope it won’t interrupt your plans 
for the day.  As more time passes, your headache gets worse, and you start to feel 
nauseated.  You head for the bedroom in hopes of snoozing the pain away.  While 
lying in bed, you suddenly realize that you can no longer move.  You want 
desperately to at least sit up, but your body just won’t no matter how hard you try; 
you are completely immobile.  You have had a stroke, likely a massive one, and 
with the way it has progressed you may not regain mobility and could even die.  
In less than a few hours from onset, you may be declared brain dead.  This is a 
very scary thought, and an extreme example, but this is a true story.  It happened 
to a very close family member of mine, who did not survive.  Yet, this story really 
shouldn’t be new to many of us.  In Canada alone, 50,000 people suffer from 
stroke each year.  This works out to one person every ten minutes (Canadian 
Stroke Network, 2008), and statistically speaking we all should, at the very least, 
know of one person who has had a stroke.  The effects of stroke can be 
devastating, with the majority of patients showing debilitating functional losses, 
and like the case just described, death.  In fact, stroke is a leading cause of death 
around the world and its prevalence is increasing with an aging population, 
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because the aged are most commonly, though not exclusively, affected (Canadian 
Stroke Network, 2008).    
 Not all stroke patients die, however, and not all outcomes are the same 
(Minn, Cho, Kim, Kwon, Kim, Oh, et al., 2008; Patel, McKevitt, Lawerence, 
Rudd, & Wolfe, 2007; Carandang, Seshadri, Beiser, Kelly-Hayes, Kase, Kannel, 
Wolf, 2006) because many variables which influence stroke manifestation and 
outcome naturally vary.  There is not a simple relationship between factors such 
as the location and size of the damage, the vascular and structural organization of 
each individual brain, impairments, recovery, and response to treatment following 
a stroke.  This thesis proposes that, among the multitude of factors that vary from 
one stroke patient to the next, individual differences in prior experience may be a 
key variable affecting stroke outcome.  A model has been developed which is 
sensitive to the differential effects of specific experiences on behavioural outcome 
following stroke.  By testing fundamental, reflexive visuomotor behaviours 
known as optokinetic tracking (OKT) in a rat model, the effects of specific 
developmental or adulthood experiences on OKT following stroke have been 
investigated.  This model of OKT quantification has shown that the behavioural 
manifestation of stroke is differentially affected by specific experiences. 
1.1 Stroke 
Stroke is classified as a cerebrovasuclar accident, caused by a sudden 
interruption of blood flow to the brain resulting in the death of neurons (Martin, 
2006).  There are two main types of stroke, ischemic and hemorrhagic.  Ischemic 
stroke comprises approximately 80% of all strokes, and is characterized by a 
 2
blood clot which interrupts blood flow to the brain (Heart and Stroke Foundation, 
2008).  Ischemic strokes can be further divided into thrombotic strokes, where the 
clot forms in an artery directly supplying the brain with blood, or embolic strokes 
in which a clot originating elsewhere in the body travels to the brain to cause a 
blockage there.  Either of these forms of ischemic attack can be permanent, or 
temporary, the latter case being termed a transient ischemic attack (Heart and 
Stroke Foundation, 2008).  Hemorrhagic strokes comprise the other 20% of 
strokes, and are characterized by a rupture of a blood vessel in the brain.  Again 
there are two sub-classifications of hemorrhagic stroke, subarachnoid hemorrhage 
and intracerebral hemorrhage.  As their names imply, subarachnoid hemorrhages 
refer to bleeding on the surface of the brain, while intracerebral hemorrhage refers 
to bleeding deeper within the brain (Heart and Stroke Foundation, 2008).  The 
most common type of stroke, however, is unilateral middle cerebral artery (MCA) 
ischemic stroke (Heart and Stroke Foundation, 2008; Canadian Stroke Network, 
2008).  
1.2 Variability in Stroke 
All types of stroke display one puzzling feature: variability.  Between 
patients, there are deviations in the location of damage caused by stroke, the size 
of the damaged area, the functions that are affected by stroke, the amount of 
recovery that each patient undergoes, and their apparent responses to treatment.  
In fact, variability seems to be a defining feature of stroke, as few patients have 
the same lesion, outcome, or general circumstances and there is no clear 
relationship between variables affecting outcome.   
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1.2.1 Variability in Lesion Location 
The first aspect of variability in stroke to be discussed is the location, in 
the brain, of the resulting lesion.  The brain is a large organ supplied with blood 
by three major cerebral arteries, the anterior, posterior, and middle cerebral 
arteries, each of which has numerous divisions and communicating arteries 
(Martin, 2006; Liebeskind, 2003; Kolb & Whishaw, 2003).  A stroke can occur in 
any of these arteries or their divisions, and so the location of the lesion will vary 
depending on which artery and which portion of an artery is blocked (Heart and 
Stroke Foundation, 2008).  For example, the posterior cerebral artery (PCA) 
artery supplies numerous regions of the posterior portion of the brain including 
the occipital lobes, the medial and inferior temporal lobes, the inferior medial 
parietal lobes, as well as portions of the midbrain and thalamus (Finelli, 2008).  
Therefore, stroke patients with a blockage in the PCA may show damage in one 
or many of these regions.  The middle cerebral artery (MCA) supplies nearly 70%  
of the brain with blood including regions of the medial cortex such as Broca’s 
area, Wernicke’s area, the pre- and post-central gyri, and the temporal and parietal 
lobes, as well as subcortical structures such as the basal ganglia and internal 
capsule (Martin, 2006).  Because of the vast part of the brain that is supplied 
blood by the MCA and its divisions, patients with an MCA stroke show very 
different locations of damage as well, in all or some of the regions which are fed 
by this artery.  Ganesan, Ng, Chong, Kirkham and Connelly (1999) discovered, in 
a study of childhood MCA territory strokes, that the location of damage varied 
greatly, as did the manifestation of symptoms and overall outcome.  The results of 
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this study show that even when a stroke occurs in the same artery, different lesion 
locations can result. 
 Though the same arteries can be found in each individual brain, their exact 
arrangement differs from person to person (Kolb & Whishaw, 2003; Lee, 1995; 
Moody, Bell, & Challa, 1990).  Individual differences in the organization of the 
brain’s vasculature can also cause variability in the location of damage caused by 
a stroke event, and may also have played a role in the result of Gaesan’s (1999) 
study.  If the same branch of the MCA was blocked in his patients, but the exact 
location of the branch differed across patients, then different lesion locations, 
symptoms, and outcomes would be expected.  This is often the case, as many 
patients with blockages of the same artery show different lesion locations within 
the brain (Rordorf, Koroshetz, Copen, Cramer, Schaefer, Budzik, et al., 1998).        
1.2.2 Variability in Lesion Size 
Each stroke patient also displays different lesion sizes, and this can be 
affected by characteristics of the blockage, the portion of the artery in which the 
blockage occurs, collateral blood supply, as well as conditions during and 
following the stroke event (Schiemanck, Post, Kwakkel, Witkamp, Kappelle, & 
Prevo, 2005). First, the larger the area of the brain that is deprived of blood, the 
larger the resulting lesion will be.  For example, a blockage which completely 
occludes an artery vs. one which causes only partial occlusion or narrowing of the 
artery, will cause greater severity of damage and larger lesion size (Heart and 
Stroke Foundation, 2008; Martin, 2006).  Also, clotting at lower portions of an 
artery, before extensive branching, will also cause greater damage than a blockage 
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further along the artery, as many more branches will be starved of blood.  
Variation in collateral blood supply, that is, arteries which indirectly feed an area, 
can also help to prevent the spread of the damage in some patients.  In this sense, 
patients will show inconsistent lesion sizes depending on the extent of the 
blockage, the point along the artery at which the blockage occurs, and the 
collateral blood supply from other arteries.  Lesion size will also fluctuate 
depending on the duration of the blockage.  This is because there is a core region 
of irreversibly injured tissue which is surrounded by an area of mild damage 
following stroke.  This region of mild damage is highly susceptible to further 
injury, and if it is not supplied with blood soon after the initial infarction, the 
damage will spread (these surrounding regions are known as the ischemic 
penumbra).  The dimensions of this penumbra and the areas of severe and mild 
damage will differ depending on the length of time until reperfusion (Kolb and 
Whishaw, 2003). The longer the brain is deprived of blood the more damage 
ensues, as there is more time for the cascading effects of the damage to expand 
into surrounding areas (Martin, 2006; Kolb & Whishaw, 2003).   
The temperature of the brain and blood during and following the initial 
stroke event can also strongly affect the outcome with respect to the size and 
depth of damage.  High temperature is conducive to cell death, and the spread of 
the ischemic penumbra (Hong, Rha, Lee, Ha, Kwon, & Kim, 2003; Thornhill & 
Corbett, 2001; Reith, Jorgensen, Pedersen, Nakayama, Raaschou, Jeppesen, et al., 
1996).  Though the exact mechanisms of the effects of temperature and causal 
relationships between temperature and infarct size have not been fully elucidated, 
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nflammation is thought to be 
conducive to cell death, and encourages the expansion of severely damaged areas 
and the ischemic penumbra following injury (Nakase, Yamazaki, Ogura, Suzuki, 
& Nagata, in press; Wang & Zhu, 2008; Wang, Tang, & Yenari, 2007; Marquardt, 
Ruf, Mansmann, Winter, Buggle, Kallenberg, et al., 2005; Nakase, Sohl, Theis, 
Willecke, & Naus, 2004; Barone & Feuerstein, 1999; Haring, Berg, Tsurushita, 
Tagaya, del Zoppo, 1996).  Though the cellular mechanisms involved in 
hyperthermia and inflammation are complex and not well understood, evidence 
has shown that both high temperature and inflammation prevent the brain from 
returning to a normal state where damaging processes will cease, and repairing 
processes can begin (Rodriguez-Yanez & Castillo, 2008).  Therefore, lesion size 
will vary depending on the temperature and inflammation in the brain before, 
during, and following a stroke.   (Cho et al., 2007) 
1.2.3 Variability in Functional Impairments 
There are many symptoms that may be described in stroke patients, 
regardless of lesion size. Functional losses are often distinct from person to 
person, and may be linked to lesion location (Rose, Brooks, & Rizzo, 2005; Petty, 
Brown, Whisnant, Sicks, O’Fallon & Wiebers, 2000; Chen, Tang, Chen, Chung, 
& Wong, 2000).  Generally, damage to posterior portions of the brain tend to 
cause visual field defects, damage to the central regions of the cortex often cause 
 7
motor disturbances, and damage to anterior regions can disrupt limbic system 
functions as well as causing disabilities of cognitive function (Martin, 2006; Kolb 
& Whishaw, 2003).  More specifically, certain aspects of a general function can 
be differentially affected by stroke between patients.  For example, damage to 
motor areas of the brain can cause impairments in upper limb function, lower limb 
function, or both (Baer & Smith, 2001; Duncan, Goldstein, Horner, Landsman, 
Samsa, & Matchar, 1994).  Certain sub-movements of the limbs can also be 
differentially affected (Gharbawie, Auer, & Whishaw, 2006; Rohrer, Fasoli, 
Krebs, Volpe, Frontera, Stein, et al., 2004; Whishaw, 2000)  Finger movements 
and placement for grasping, wrist movements, and directional arm movements 
can each be affected separately or in combination following motor cortex stroke 
(Nakayama, Jorgensen, Raaschou, & Olsen, 1994).  These studies investigating 
behavioural outcome following stroke have shown that specific impairments in 
function can vary.   
1.2.4 Variability in “Spontaneous” Recovery of Function 
Further variability in stroke occurs with recovery of lost function (for 
review see Kollen, Kwakkel, & Lindeman, 2006; Cramer, 2008; Cramer & 
Bastings, 2000).  Current statistics from the Canadian population show that 10% 
of patients recover completely, and appear to be unimpaired by the stroke event 
(Heart and Stroke Foundation, 2008).  Other patients recover only certain aspects 
of their original abilities (Bonita & Beaglehole, 1988).  Of all stroke patients, 25% 
are said to recover with minor impairments, and 40% are left with moderate to 
severe disabilities.  Approximately 10% of stroke patients, however, do not show 
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signs of recovery at all, and are so debilitated by the stroke that they need  
assistance with many aspects of daily care (Heart and Stroke Foundation, 2008;  
Rothwell, Coull, Giles, Howard, Silver, Bull, et al., 2004).  The extent of recovery 
of function is clearly inconsistent across patients, and can also be influenced by 
factors other than the stroke itself.  
1.2.5 Variability in Treatment Effects 
Finally, the main problem with stroke today is that there is a lack of 
effective treatments for stroke patients.  Those treatments that are available vary 
from drug administration, to surgery, behavioural therapies, or combinations of 
these, although none of the available treatments have proven satisfactory. Many 
patients have shown large increases in functional ability after treatment or 
therapy, while other patients have shown only minor effects of the same treatment 
(Mirbagheri & Rymer, 2008).  For example, a recent clinical trial of Minocycline, 
a second generation derivative of tetracycline known to have neuroprotective 
effects in rodent models, showed a significant increase in behavioural outcome 
following treatment (Lampl, Boaz, Gilad, Lorberboym, Dabby, Rapoport et al., 
2007).  Though raw scores were not provided, the variability in behavioural 
assessment scores were more than 50% of the reported improved score, 
suggesting that not all patients recovered to the same degree, and a wide range of 
variability in outcome measures.  Another study tested the effects of a behavioural 
treatment, constraint-induced movement therapy, and showed great variability in 
functional outcome as well (Wolf, Winstein, Miller, Thompson, Taub, Uswatte, et 
al., 2008).  Patients’ recovery varied depending on the measure, the amount of 
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time from stroke to the beginning of therapy, initial impairments, and follow-up 
time period.   
In addition to these studies, others have shown that the amount of time it 
takes for treatments to show beneficial effects is inconsistent.  Some patients 
apparently respond immediately to treatment and show signs of recovery in days 
or weeks following treatment onset (Stinear, Barber, Coxon, Fleming, & Byblow, 
2008; Lampl et al., 2007; Celnik, Hummel, Harris-Love, Wolk, & Cohen, 2007) 
whereas others seem to take months or even years to show functional 
improvements (Kwakkel,  Kollen, & Twisk, 2006; Schiemanck et al., 2005; 
Meldrum, Pittock, Hardiman, Ni Dhuill, O’Regan, & Moroney, 2004; Broeks, 
Lankhorst, Rumping, & Prevo, 1999; Duncan et al., 1994; Dam, Tonin, Casson, 
Ermani, Pizzolato, Iaia & Battistin, 1993).  Overall, there is little consensus on the 
benefits of any of the available treatments and therapies, and results of treatment 
trials have been largely inconsistent (Kwakkel, Kollen, & Krebs, 2008; Stinear et 
al., 2008; Martinsson, Hardemark, & Eksborg, 2007; Merino, Latour, Todd, Luby, 
Schellinger, Kan, et al., 2007; McCain, Pollo, Baum, Coleman, Baker, & Smith, 
2008; Lampl et al., 2007; Rose et al., 2005; Kidwell, Liebeskind, Starkman, & 
Saver, 2001).    
 Variability in stroke location, size, impairments, recovery, treatment 
success and overall behavioural outcome make treating stroke and developing 
new treatments difficult for researchers and clinicians.  There is insufficient 
knowledge available about which treatment options will be beneficial for which 
patient and why (Pollock, Baer, Langhorne, & Pomeroy, 2007; Kolb & Whishaw, 
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2003).  It is necessary to know which treatment to assign to each patient to ensure 
that they have the best chance for recovery, and the best possible outcome.  
Unfortunately, this knowledge is currently lacking.  Until the factors underlying 
variability in stroke are better understood, progress in stroke treatment will 
undoubtedly remain limited. 
1.3 Causes of Variability  
Recently, researchers have attempted to determine the cause of the vast 
amount of variability in stroke.  By holding constant many of the variables 
associated with stroke, such as age, demographics, infarct location and size, 
stroke subtype, and clinical impairments, attempts have been made to account for 
biologically relevant variability in stroke outcome (Ottenbacher, Campbell, Kuo, 
Deutsch, Ostir, &Granger, 2008; Prabhakaran, Zarahn, Riley, Speizer, Chong, 
Lazar et al., 2008; Broeks et al, 1999).  In spite of these attempts, unexplained 
variability remains present in all stroke studies and the manifestation and 
consequences of stroke remain differential across patients, regardless of the 
number of variables which are controlled.  Results of stroke studies suggest that 
there may be other sources of variability which have not yet been fully 
characterized.    
1.3.1 Individual Experience 
 Though our brains are slightly different at birth, for the most part, they are 
a blank slate prepared to respond to the world.  When we are born, our brains are 
still developing, and this development is influenced by the environment.  
Therefore, it is not until we begin to grow in the environment that our brains 
 11
begin to organize themselves and function in very different ways, and we become 
very different people (Keverne, 2004).  The gross morphology of the brain 
remains similar between individuals throughout life, but differences in vascular 
and synaptic organization and specific functioning of each individual brain 
become more apparent as we age (Prabhakaran et al., 2008; Kolb & Whishaw, 
1998; Kolb, 1995).  It has become commonly known that the brain is a plastic 
structure, and that changes occur in response to experience, the environment, and 
to injury throughout life (Gauthier, Taub, Perkins, Ortman, Mark, & Uswatte, 
2008; Prabhakaran et al., 2008; Kolb, 1995; Kolb, Gibb, & Robinson, 2003).  The 
experiences that each individual has and the brain’s responses to those 
experiences are often unique, and so the changes that occur in the brain because 
of these experiences are also individually distinct (Prabhakaran et al., 2008; Kolb, 
1995).  Therefore, individual differences in organization, structure, and function 
of the brain may be related to the life experiences that help to shape our brains.   
Since differences in each brain, such as vascular and structural 
organization, are related to differences in stroke outcome, it may be that the 
experiences that a person has in life are also linked to the variability in stroke 
location, size and depth, impairments, recovery, and overall outcome.  A key to 
unlocking the puzzle of variability in stroke manifestation and outcome may lie in 
individual differences in experience.   
1.4 Hypothesis 
If, in fact, our life experiences cause the variability that occurs with stroke, 
then how can we use this information to help those affected by stroke?  Part of the 
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difficulty in treating stroke patients is that we cannot immediately determine how 
they will be affected.  Accurate estimation of a patient’s prognosis soon after the 
stroke may allow clinicians to start the appropriate treatment at an optimal time 
(Canadian Stroke Network, 2008; Gilman, 2006).  The earlier a patient’s needs 
for recovery can be determined, the earlier those needs can be fulfilled through 
treatment.  If a certain experience is known to lead to specific functional losses 
after stroke, we may be able to make better predictions about a patients’ 
functional outcome based on some of the major experiences they have had.  For 
example, if learning to play the guitar results in similar plastic changes in the 
brains of all individuals then information can be gathered from stroke patients 
who played guitar before their stroke, and knowledge about their outcome can be 
applied when making predictions about the prognosis of new guitar playing stroke 
patients.  Similarly, if working in construction causes certain changes in the brain, 
we can also look at past construction workers who have had a stroke, and apply 
information about their functional outcome and recovery to new patients who 
have also worked in construction.  Overall, understanding the effect that 
environmental experience before a stroke has on stroke outcome promises to 
enable better characterization of strokes, and may help to control some of the 
variability seen in stroke treatment trials.  The key is to know what to expect, so 
that we can combat the loss of function that a patient will experience with the 
greatest accuracy and at the most appropriate time.   
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The following studies aim to investigate individual experiences as a factor 
influencing stroke manifestation, and hypothesize that variability in behavioural 
outcome is affected by individual differences in experience. 
But can variability caused by experience be represented by meaningful 
quantitative measurements?  In essence, a seemingly simple experiment is 
necessary.  First, one must have a quantitative test of functional ability which is 
sensitive to plastic changes in the brain caused by experience.  After looking at 
natural ability, a novel experience must then be introduced.  With record of 
functional ability before and after a given experience, the effects of stroke on that 
function can then be examined.  Final testing after the stroke can give insight into 
how the experience influenced the loss of function.  Changes in function can also 
be compared to participants who have not been exposed to new experiences.  This 
will allow for analysis of the degree of variability that can be said to be caused by 
the experience itself.  Overall, all that is necessary is a test of function, a new 
experience, and a stroke, and with these three factors we can look at variability 
caused by experience.  Implementing these factors into a model of stroke will 
allow researchers to gain experimental control over the effects of experience on 
stroke outcome. 
1.5 Model of the Effects of Experience on Stroke Outcome 
The model utilized in this thesis follows the above guidelines using rat 
subjects.  There are many specific requirements that must also be met in 
developing such a rodent model, as described by Willott and colleagues (2003).  
First, the test of function must be observed in both rodents and humans, and must 
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be applicable to everyday life.  Secondly, measurements must be accurate, easy, 
and relatively quick to obtain.  More importantly for this model, the measure must 
be sensitive to the differential effects of specific experiences on the brain, both 
during development and in adulthood.  The model as a whole also needs to allow 
for a large amount of control over experience, and the method of stroke induction 
should also limit variability in the location and size of damage from stroke.  These 
conditions have been met in the following model.    
1.5.1 A Fundamental Vertebrate Behaviour 
Many potential stroke treatments have proven successful in animal models 
(Shukla, Khanna, Ali, Khan, & Srimal, 2008; Aldandashi, Noor, Wang, Uddin, & 
Shuaib, 2007; Hemmen & Lyden, 2007; Gonzalez, Gharbawie, & Kolb, 2006).  
However, a discrepancy remains between animal and human trials of stroke 
treatments, in that many of the positive results obtained in animal models have not 
been confirmed in humans (Shin, Moon, & Bang, 2007; Martinsson, Hardemark, 
& Eksborg, 2007; Lampyl et al., 2007; Wang, Sun, Simonyi, Jensen, Shelat, 
Rottinghaus, et al., 2005; Martinsson & Eksborg, 2004; Gladstone, Black, & 
Hakim, 2002).  Why is it that a treatment can be successful in rodent models but 
then show few, if any, positive effects for humans?  It’s obvious that humans and 
rodents are not alike in many ways, physiologically, behaviourally, and even at 
the cellular level.  Of importance here though, is the fact that certain functions 
which are commonly used as measures of stroke recovery in rodents may not be 
equivalent to measures used in humans.  For example, does ladder walking in 
rodents relate directly to walking in humans?  Clinicians certainly do not make 
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patients walk along a horizontal ladder to test their impairments.  However, if the 
measure of function is essentially the same in all species, then the effects of stroke 
on that measure may also be similar across species.   
One of the best ways to guarantee that the function being investigated is 
the same in different species is to use a function that has not been changed 
evolutionarily, one that draws on mechanisms from many regions of the brain but 
remains a reflexive response.  The following studies take advantage of such a 
response, in hopes of beginning to solve the problem of non-transferability of 
treatments between species.   
1.5.2 Optokinetic Tracking (OKT) 
In the following studies the test of function is a visuomotor test of the 
optokinetic tracking (OKT) (Prusky, Silver, Alam, & Douglas, in press; Alam, 
Rakai, Jadavji, Metz, Douglas, & Prusky, 2008; Prusky, Alam, & Douglas, 2006; 
Douglas, Alam, Silver, McGill, Tschetter, & Prusky, 2005; Prusky, Alam, 
Beekman, & Douglas, 2004; Prusky, Douglas, 2004; Prusky, Harker, Douglas, & 
Whishaw, 2002; Prusky, Reidel, & Douglas, 2000; Prusky, West, & Douglas, 
2000).  OKT is a primitive response that can be seen in all vertebrate species 
(Schwartz, 1999).  When a moving object passes through the visual field, the 
initial response of an animal is to stabilize the image on the retina.  This results in 
movement of the head and neck at a similar speed as the movement of the 
stimulus (Schwartz, 1999).  This motion of the head and neck is referred to in this 
thesis as “tracking”.  Movement is a strong visual stimulus that reflexively results 
in this tracking motion.     
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1.5.3 Virtual Optomotor System (VOS)        
The method of testing described here is not a strict test of vision (though it 
has been used as a test of motion vision in the past by McGill, Lund, Douglas, 
Wang, Lu, Silver, et al. 2007; Prusky, Alam, Beekman, & Douglas, 2004; 
Douglas, Alam, Silver, McGill, Tschetter, & Prusky, 2005).  In fact, vision itself 
is not simply a single function.  Vision is much more a sensory integrative 
process, as input to the visual system is used for many different functions, 
especially in humans.  Visual input is almost always responded to in some way, 
most commonly with a motor response.  For example, if you see a truck moving 
toward you, you move out of the way.  Or if you see something you want, you 
reach for it.  To interact with the environment, visual information is used to elicit 
motor responses, and this is essentially what the following virtual optomotor 
system (VOS) test examines.  For these reasons, this test is much more applicable 
to real life situations than tests of visual discrimination or visual acuity (Prusky, 
West, & Douglas, 2000; Douglas, Alam, Silver, McGill, Tschetter, & Prusky, 
2005). 
Using a virtual optokinetic system (VOS) described in detail previously 
(Prusky, Alam, Beekman, & Douglas, 2004; Douglas, Alam, Silver, McGill, 
Tschetter, & Prusky, 2005), spatial frequency (SF), and contrast sensitivity OKT 
thresholds were measured in rats.  The apparatus consists of four computer 
monitors which face toward each other to create a square box testing arena.  The 
animal is placed on a platform within the testing arena, and moving sine wave 
gratings are presented on the monitors.  The animal reflexively tracks the gratings, 
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and the spatial frequency and contrast of the grating is adjusted in a staircase 
manner until the animal no longer tracks the stimulus.  The last value at which the 
animal tracks the stimulus is recorded as the OKT threshold.  The apparatus, then, 
is measuring the animal’s tracking response to moving visual stimuli.  Overall, 
obtaining SF thresholds and contrast sensitivity curves for both eyes is relatively 
fast, and takes approximately 45 minutes or less. 
1.5.4 Experience  
Since inbred laboratory strain rats are genetically very similar, and their 
environment is also very similar (because they are raised in the same shoebox 
cages in the same colony room throughout life), it is possible to subject them to 
only a few novel experiences.  This allows for greater control over the plasticity 
that occurs in response to new experiences or environments.  Other animal models 
may allow for experience to be restricted, but the genetic differences in higher-
order animals are greater, and many require more care and therefore more 
experience in their lifetime.  The goal is to keep experiences as limited and as 
constant as possible, and this is most easily accomplished with a rat model.   
Many experiments have shown that deprivation of visual experience in 
rats can result in different functional abilities and outcomes than in non-deprived 
animals (Maffei, Nataraj, Nelson, & Turrigiano, 2006; Prusky et al., 2006).  In the 
following experiments, however, instead of depriving animals of experience, two 
specific experiences have been added to the normal experiences of the typical 
laboratory rat; one experience during development, and the one in adulthood.  
Deprivation studies provide necessity measures, whereas testing the effects of 
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adding new experience will provide a sufficiency measure to analyze the effects 
of experience on brain plasticity. 
1.5.5 Stroke Induction 
Stroke induction is the final piece of these experiments.  There are many 
methods of inducing stroke in rodents (for review, see Hossmann, 2007).  The two 
methods chosen for the following studies are both permanent ischemic models.  
The first is MCA occlusion by electrocoagulation, and the second, primary visual 
cortex (V1) devascularization.  The method of MCA occlusion that has been 
chosen for this experiment was initially developed by Tamura et al. in 1980, and 
results in a non-reversible permanent occlusion of the MCA.  By clamping the 
carotid arteries immediately after occluding the MCA, the time frame in which we 
can be certain that reperfusion did not occur can be controlled.  As mentioned 
earlier, the duration of the blockage of blood flow can drastically change the 
anatomical outcome after a stroke, and with the method used here this variability 
is controlled to a much greater extent than with other MCA occlusion methods 
(Hossmann, 2007).  
A stroke induction method known as “pial strip” was used to induce 
lesions in the primary visual cortex (V1).  This method of devascularization has 
been used extensively as a model of cerebral damage and stroke (Gonzalez & 
Kolb, 2003; Kolb, Cote, Ribeiro-da-Silva, & Cuello, 1997; Goldstein & Oakley, 
1987; Sofroniew, Pearson, Eckenstein, Cuello, & Powell, 1983).  
Devascularization is a permanent stroke model, as there is nothing left in this area 
to reperfuse once the vessels and arteries have been wiped away.  Other methods 
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of inducing visual cortex damage, such as posterior artery occlusion, do not 
selectively damage the visual cortex alone (Finelli, 2008).  Because V1, our area 
of interest, is located immediately under the skull and is easily accessible by 
removing only a small square of skull, the pial strip method is efficient, reliable, 
quick, and relatively non-invasive.  It is also known to cause very similar damage 
from one animal to the next, limiting variability due to lesion location and size. 
Overall, this model meets the requirements set out by Willott et al. (2003), 
and follows the guidelines necessary to test the effects of experience on stroke 
outcome.  Rodent models allow for many of the factors that naturally vary in 
humans and other animal species to be held constant, and therefore have been 
used in the following experiments.       
1.6 Introduction to the Chapters 
In this thesis, Chapter 2 will examine the effects of stroke on OKT 
behaviour of normal rats, and rats with developmental visual experience. Chapter 
3 will explore the effects of adulthood motor experience on OKT thresholds 
following stroke.  Chapter 4 will look at the effects of combining developmental 
visual and adulthood motor experience on OKT function after stroke.  Finally, 
Chapter 5 will be dedicated to a discussion of the results, and future directions for 
this research.  
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Chapter 2 – Effects of Stroke in Rats With and Without Developmental  
Visual Experience 
2.1 Enhancing OKT With Developmental Visual Experience 
 In order to test the effects of experience on stroke outcome it is first 
necessary to characterize normal function, and the effects of stroke on normal 
function.  Such information will provide a foundation from which to compare the 
effects of experience on stroke.  This chapter will introduce the characteristics of 
optokinetic tracking (OKT) behaviour in normal inexperienced animals, and the 
effects of stroke on their OKT behaviour.  OKT thresholds have previously been 
characterized in normal rats (McGill, Prusky, Douglas, Yasumura, Matthes, Nune, 
et al., 2007; Silver, 2003).  Results from the present experiment are comparable to 
previous studies, as will be described below, and show that normal Long Evans 
rats’ OKT threshold measurements are consistently found to be approximately 
0.52 to 0.54 cycles per degree (c/d).  Studies of the effects of visual cortex 
aspiration and inactivation on normal animals’ OKT thresholds have found that 
such methods deny enhancement of OKT (Silver, 2003; Prusky & Ramoa, 1999).  
Yet, the effects of other models of stroke on OKT behaviour have not previously 
been reported.  The following study will examine OKT behaviour following 
MCAo and V1 devascularization stroke models.     
 The effect of developmental visual experience on OKT behaviour after 
stroke will also be examined here.  Developmental experience often has lasting 
effects on the brain and behaviour (Kleim & Jones, 2008; Hooks & Chen, 2007; 
Gibb & Kolb, 2005; Kolb, Gibb, & Gorny, 2003; Kolb, 1995).  Evidence of this 
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phenomenon on visuomotor behaviour originates from research in the Prusky lab, 
which has shown that exposing rats to approximately 30 minutes of VOS testing 
every day from P15 to P30 significantly enhances rats’ OKT spatial frequency 
(SF) threshold measures, as tested by the virtual optomotor system (VOS) 
described earlier (Prusky, Silver, Alam, & Douglas, in press; Silver, 2003).  
Specifically, OKT thresholds are significantly increased by approximately 60% as 
a result of developmental visual experience (Silver, 2003).  As changes in 
behaviour correlate with changes in the brain, and the OKT behaviour is changed, 
the assumption can be made that the brain has changed in some way as well.  
Therefore, less than 45 minutes of daily early life experience forms enduring 
changes in the brain, as OKT thresholds of experienced animals do not revert to 
pre-experience values over time and are considered permanent (Prusky, et al., in 
press; Silver, 2003).   
Silver (2003), in hopes of finding the location in the brain of these plastic 
changes, removed the primary visual cortex (V1) of P15-P30 experience 
enhanced animals via aspiration lesion.  He found that after removing the primary 
visual cortex, normal animals’ OKT thresholds were unaffected.  In 
developmentally experienced animals, however, OKT thresholds reverted to 
values similar to normal animals, which were not subject to the enhancing 
experience.  In addition, animals with P14 visual cortex aspiration, just prior to 
the commencement of the developmental experience, never improved beyond that 
of a normal animal.  The conclusion drawn from this experiment was that the 
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plasticity that allowed for the increase in OKT thresholds may have relied on the 
visual cortex, since its removal eliminates the effects of the experience.   
The visual cortex is clearly involved in the production of OKT behaviour 
in visually experienced animals.  However, OKT behaviour involves both a visual 
component (a visual stimulus) and a motor component (motor output in the form 
of tracking).  Since it is now known that a motor task can enhance OKT 
(unpublished data), the prediction can be made that visuomotor, motor, or sensory 
association areas of the cortex may also play a role in the enhancement of OKT.  
In fact, it has been predicted that the majority of the synaptic connections that are 
activated during OKT are those that do not travel through the visual 
thalamocortical pathway from the retina to the visual cortex, and therefore may 
connect in motor or association areas of the brain (Douglas, Alam, Silver, McGill, 
Tschetter, & Prusky 2005).     
The pathway activated by moving visual stimuli, and which produces the 
motor output of OKT, may have the ability to be disturbed in absence of reduced 
visual function.  That is, without causing any damage to the visual system, there 
may be a way of disturbing the OKT motor response alone, without affecting the 
visual side of OKT.  Damage to motor or association areas of the cortex may 
interfere with the motor output aspect of OKT, while leaving vision intact.  This 
will also be indirectly examined in the following experiment.   
2.2 Effects of Two Stroke Models on OKT Thresholds 
In order to show how developmental visual experience affects visuomotor 
behavioural outcome after stroke, OKT thresholds were evaluated in normal 
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animals following MCA occlusion (MCAo) and V1 stroke.  OKT thresholds of 
rats with developmental visual experience were also examined following 
experience and following stroke.   
Method 
Animals were housed and handled according to Canadian Council on 
Animal Care (CCAC) standards, under the supervision of the University of 
Lethbridge Animal Care Committee. 
Nine male and 1 female Long Evans (LE) hooded rats were used in this 
experiment (N = 10), as well as 12 male age-matched control rats of the same 
species.  No sex differences were apparent in these experiments.  All animals 
were bred in the Canadian Centre for Behavioural Neurosciences (CCBN) 
vivarium, with original stock obtained from Charles River.  The animals were 
housed in polycarbonate cages (45.5cm L x 25.5cm W x 20cm H) in the 
University of Lethbridge colony room, which was maintained at an ambient 
temperature of 21 degrees Celsius, 35% relative humidity, and a light/dark cycle 
of 12h/12h.  The animals had access to food and water ad libitum throughout the 
study.  Animals were weaned at approximately 22 postnatal days, at which time 
males and females were separated and housed in identical conditions in the colony 
room.   
Virtual Optokinetic System (VOS) Apparatus 
Using a virtual optokinetic system (VOS), described in detail previously 
(Prusky, Alam, Beekman, & Douglas, 2004; Douglas, Alam, Silver, Mcgill, 
Tschetter, & Prusky, 2005) SF thresholds were measured in rats (contrast 
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sensitivity thresholds are available in Appendix B).  The VOS is a relatively new 
method of testing SF thresholds and contrast sensitivity thresholds.  The system 
consists of four computer monitors (in this study, 19 inch Dell monitors) that face 
toward each other forming a square box testing arena, and are held together by a 
black Plexiglas frame (Figure 1).  In the center of the arena, a pole extends from 
the floor of the box to 6” above the bottom surface of the box.  A circular 
platform sits atop this pole, and is where the animal is placed for testing.  The 
inside top and bottom of this box are mirrored so that stimuli on the computer 
monitors are replicated both up and down, creating the illusion that the box 
continues on indefinitely from the animal’s viewing position.  The top of the 
apparatus opens to gain access to the inside, and a small Apple iCam is built into 
the center of the lid so when an animal is inside, the lid can be closed and the 
animal observed in real time on a separate computer monitor.  Using the 
accompanying software (Optomotry 1.7.0), the image of the animal appears on a 
viewing monitor, and a crosshair cursor is used to center the stimuli.  The 
computer monitors show a uniform grey screen, but the observer can change their 
output to resemble a rotating cylinder. The stimuli in this experiment, though it 
can be changed, consisted of sine wave gratings of black and white moving at 12 
degrees/sec.  This is much the same as the rotating cylinder method used to make 
types of measurements in the past (Thomas, Seiler, Sadda, Coffey, & Aramant, 
2004; Harvey, De'Sperati, & Strata, 1997; Cowey & Franzini, 1979).  The ability 
to move the center of the cylinder to the animal’s head with the crosshair prevents 
mis-measurements, as the center of the virtual cylinder is always centered on the 
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animal, and the movement of the animal does not affect its distance from the 
stimuli, and therefore the measurement.  The animal’s movement need not be 
restricted, and because the response is reflexive, training is not necessary.   
Behavioural Testing in VOS 
To obtain a threshold, the observer must watch the animal and note its 
optokinetic response to the moving stimuli.  A small but noticeable tracking 
motion is made by the animal in response to the moving grating.  The tracking 
motion of the animal can be seen to get smaller and smaller with increasing 
spatial frequencies, until it is no longer detectable.  The last point where the OKT 
can be seen is recorded as the threshold.  The SF threshold is obtained by 
adjusting the spatial frequency of the grating while keeping the contrast between 
the black and white regions at 100%.  Contrast sensitivity can also be measured 
with this apparatus, and is accomplished by adjusting the contrast of the black and 
white gratings at different spatial frequencies.  In our lab, we use up to 9 spatial 
frequency points to create a contrast sensitivity curve.  The points chosen (0.031, 
0.064, 0.092, 0.103, 0.119, 0.272, 0.403, 0.603) are based on the contrast 
sensitivity curve itself.  Previous testing in our lab has shown that 0.103 
cycles/degree (c/d) is the peak spatial frequency for rats, and the other points are 
placed evenly around this peak.  By adjusting the contrast of the grating at these 
spatial frequencies, we can obtain a reliable contrast sensitivity curve.  To obtain 
contrast sensitivity values, a Michelson contrast is calculated from the screen 
luminance (maximum - minimum) / (maximum + minimum), and the reciprocal is 
recorded as the contrast sensitivity. 
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One benefit to using this system is that it allows for the stimuli to be 
restricted to certain portions of the animal’s visual field (Figure 2). This may be 
useful in the following experiments because visual field defects often arise 
following stroke (Kerkhoff, 2001; Cassidy, Bruce, & Gray, 2001).  Here, 
monocular field SF thresholds are also obtained for each eye (contrast sensitivity 
curves for the monocular visual field can be found in Appendix B).  Stimuli are 
placed only from 35 degrees to 145 degrees from the center of the animal’s visual 
fields.  This is accomplished by using a T-shaped cursor which rotates so that the 
observer can center the “T” on the animal’s eyes and down the length of its nose.  
Though the monocular field begins at 30 degrees in rats, we start the stimulus at 
35 degrees to allow for 5 degrees of observer error due to cursor placement.  
Experimental Timeline 
 In all experiments, in this chapter and the upcoming chapters, the 
experimental timeline began with baseline testing of OKT thresholds, prior to any 
form of novel experience (for the developmentally enhanced animals, P15-P30 
testing comprised the baseline measurements).  After baseline measurements had 
been obtained, thresholds were tested post-experience.  For groups receiving both 
MCAo and V1 devascularization lesions, MCA stroke was induced first.  
Thresholds were obtained 2 days, 1 week, and 2 weeks following the stroke, after 
which the unilateral V1 lesion was induced contralateral to the MCAo damage.  
Testing resumed again for a 2 week period, and the day following the 2 week 
testing session, bilateral V1 damage was induced.  The timeline was the same for 
animals without MCAo, except that the first lesion was a unilateral V1 
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devascularization, on a randomly assigned hemisphere, followed 2 weeks later by 
the bilateral V1 lesion. 
Experience 
 Animals were placed in the VOS system each day from eye opening (P15) 
to P30.  Full field SF thresholds and contrast sensitivity thresholds were obtained 
each day, approximately 45 minutes of experience or less.  This process has been 
shown to enhance the animals’ SF thresholds well above those of adult animals 
which have not been tested in this apparatus previously, referred to as “normal” 
animals (Silver, 2003).  This enhancement has also been shown to be permanent, 
and thus, once testing from P15 to P30 was completed, the animals remained in 
their home cages until they reached adulthood, a minimum of 80 days of age. 
OKT Testing 
 For each testing session in adulthood, animals were placed in the VOS 
system for approximately 30-45 minutes of testing.  Full visual field SF 
thresholds and both monocular visual fields’ SF thresholds were obtained as 
described earlier.  Testing took place the day prior to stroke induction and again at 
three time points after each stroke; two days post-stroke (2D), one week post 
stroke (1W), and two weeks post stroke (2W).  Spatial frequency measurements 
were randomly double-checked by an outside blind observer. 
Stroke 
MCA Occlusion 
 A permanent occlusion model was used for MCA stroke in this study.  
Animals were anesthetized with 2% isofuorane evaporated in 1.5L/min oxygen 
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via nose cone administration.  A heating pad was used to keep animals’ body 
temperature at 37.5 degrees Celsius throughout the surgery.  Opthalamic ointment 
(BNP) was applied to the eyes, and the neck and top of the head were wiped with 
diluted hibitane and 70% alcohol.  With the animal lying on its back, an incision 
was made from the chest bone rostrally approximately 1.5cm, and the underlying 
tissue exposed.  The underlying connective tissue was gently cut to reveal the 
neck muscles, which were then gently separated and held aside using a saline 
dampened swab.  The carotid artery could then be located.  Fine curved tweezers 
were used to carefully isolate the carotid and separate it from the attached Vagal 
nerve.  A soft string was then wrapped around the carotid so it could be easily 
located later, and the incision was pressed shut with the strings out.  Saline was 
applied as necessary to keep the area moist. 
 The animal was then moved to the stereotaxic apparatus, where a midline 
incision was made, approximately 1.5 cm in length.  The skin was held aside with 
small hemostats and a #11 scalpel blade was then used to detach the muscle from 
the sagittal ridge.  The muscle was then held aside using a small thin spatula, 
while an opening was drilled lateral to the sagittal ridge using a 1mm dental burr.  
The opening began approximately 1mm anterior to bregma to approximately 5mm 
posterior to bregma, and extended from just above the mandible joint, 4 mm 
dorsally.  With this section of the skull removed, the MCA could be viewed, and 
the dura was gently removed using fine tipped tweezers.  Current conducting 
tweezers were then plugged into a bipolar electrocoagulator (SMT BM, Czech 
Republic), set at an arbitrary intensity of 2, and by placing the tweezers’ tips on 
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either side of the MCA, current passed through the space between the tips of the 
tweezers to coagulate the MCA.  The animal was then quickly removed from the 
stereotaxic apparatus, and both carotids were clamped with micro-aneurysm 
(ROBOZ) clamps for 30 minutes to ensure that the MCA area was not reperfused.  
After this time period, the clamps were removed and both incisions were sutured 
with standard monofilament suture material.  Polysporin was applied to the 
incisions to aid healing, and 1ml Saline and 0.03ml buprenorphine (torbusec) 
were administered subcutaneously.  Animals were given food and water ad 
libitum for 24 hours while being monitored in the surgery preparation area.  
Mashed food combined with water was also supplied to the animals to ensure 
easy intake of food.  Animals were returned to their home cages in the colony 
room after 24 hours of monitoring their recovery from the procedure. 
V1 Pial Strip 
 Induction of anesthesia was accomplished using 4-5% inhaled isofourane 
and was held at 2% inhaled isofuorane evaporated in 1.5L/min oxygen via nose 
cone administration throughout the procedure.  Animals were also placed on a 
heating pad throughout surgery to maintain body temperature at 37.5 degrees 
Celsius.  Once anesthetized, ear bars were used to place the animal in a 
stereotaxic apparatus, keeping the head immobile.  Opthalamic ointment (BNP) 
was applied to the eyes, and the top of the head was wiped with diluted hibitane 
and 70% alcohol.  An incision was made down the midline, approximately 1.5 cm 
in length.  The skin was then resected and held aside with small hemostats.  An 
opening was made in the skull using a 1mm dental drill, from 6mm to 12mm 
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posterior to bregma, and from 1mm lateral to bregma to the sagittal ridge, the area 
defined as V1 by Paxinos and Watson (1998).  This square of skull was then 
removed, and the underlying dura was carefully peeled off using fine tipped 
tweezers.  With the dura removed and the brain exposed, a cotton swab was 
dampened with Saline and was used to wipe the vasculature off of the exposed 
brain surface.  The incision was then sutured closed using standard suture 
material, and Polysporin was smoothed over the sutures to aid healing.  Animals 
were also given 0.03ml of buprenorphine (torbusec) and a 1ml injection of Saline 
subcutaneously before being removed from the stereotaxic apparatus.  Food and 
water were available to the animals ad libitum for 24 hours while being monitored 
in a surgery preparation area.  Animals were returned to their home cages after 24 
hours of monitoring their recovery. 
Histology 
Once testing was completed, the animals were sacrificed to verify lesion 
boundaries.  An intraperitoneal injection of 0.7ml Euthansyl was used to 
anesthetize the animals.  Once all reflexive responses were absent, the animals 
were perfused with 1% buffered saline and 4% paraformaldehyde.  The brains 
were removed and kept in 4% paraformaldehyde at room temperature for 48 
hours, at which point they were placed in 30% sucrose solution until slicing.  
Digital pictures of the dorsal surface of the brains were taken before slicing for 
quantification of the surface features and lesion boundaries.  Brains were sliced 
on a microtome (American Optical, model #860; Buffalo, NY, USA) at 40 μm 
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thickness, and mounted on slides.  After mounting, the brains were stained using 
Cresyl Violet to view the depth of the damage.   
Statistical Analyses 
Repeated measures analysis of variance (ANOVA) was used to analyze 
the SF threshold at each testing time for each group, as well as for comparisons 
between each group and controls (Statview, Version 5.0.1.0, SAS Institute Inc.).  
Follow-up paired t-tests were used to analyze between testing sessions data, and 
unpaired t-tests were used to compare within testing session effects (comparisons 
between contralateral and ipsilateral to lesion visual fields).  The alpha level for 
this experiment was set at 0.05.   
Results 
 Results showed no effect of MCAo for all groups.  V1 lesions 
significantly reduced full field OKT thresholds. 
Normal Rats (animals without experience) – MCAo - Full Field SF Thresholds 
 Repeated measures ANOVA failed to reveal a significant interaction in 
inexperienced normal rats (F(1, 3) = 0, p = 0.0).  There was no effect of MCA 
occlusion on OKT full visual field thresholds, which were recorded as 0.530 ± 
0.002 c/d.  This effect, or lack thereof, also applied to monocular visual field 
thresholds which remained at 0.489 ± 0.004 following the MCA territory lesion 
(F(1, 3) = 0, p = 0.0).   
Normal Rats - V1 Lesions - Full Field SF Thresholds 
Analyses showed no significant differences between baseline thresholds, 
and those obtained after MCA occlusion in normal rats.  However, repeated 
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measures ANOVA did reveal a significant main effect of testing time (F(1, 6) = 
76.443, p < 0.0001), as well as a significant interaction (F(1, 6) = 80.375, p < 
0.0001) for the sequential V1 lesion data.  Follow up paired t-tests revealed 
significant differences between pre-stroke measures and all post V1 stroke time 
points (2D post unilateral V1: t(15) = 3.719, p = 0.0021; 1W post unilateral V1: 
t(15) = 3.719, p = 0.0021; 2W post unilateral V1: t(15) = 3.742, p = 0.0020; 2D 
post bilateral V1: t(15) = 15.056, p < 0.0001; 1W post bilateral V1: t(15) = 
14.334, p < 0.0001; 2W post bilateral V1: t(15) = 12.314, p < 0.0001), which 
suggested that the V1 lesions significantly reduced OKT thresholds.  Other 
significant differences were apparent between 2D after unilateral V1 lesion and 
2D after bilateral V1 lesion (t(15) = 2.260, p = 0.0392), as well as between 1W 
after unilateral V1 lesion and 2D after bilateral V1 lesion (t(15) = 2.260, p = 
0.0392), which showed that unilateral V1 lesions significantly reduced thresholds 
measured through the eye contralateral to the lesion.     
Unpaired t-tests revealed significant differences between the ipsilateral 
and contralateral visual fields as well.  Two days, one week, and two weeks after 
the unilateral V1 lesion, the contralateral and ipsilateral visual fields were 
significantly different from each other (t(14) = -10.954, p < 0.0001; t(14) = -
10.954, p < 0.0001; t(14) = -11.124, p < 0.0001, respectively).  These data 
implied that following a unilateral lesion, thresholds obtained through each eye 
were significantly different, that is, thresholds from the visual field contralateral 
to the lesion were reduced, yet the ipsilateral visual field was not affected until 
induction of the bilateral lesion.  These data are available in Figure 5, and lesion 
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boundaries for this group can be found in Figure 4.  Figure 3 shows typical MCAo 
and V1 lesion damage for all groups.     
Normal Rats - V1 Lesions - Monocular SF Thresholds 
Repeated measures ANOVA exposed a significant interaction for 
monocular visual field data of normal rats as well (F(1, 6) = 9.463, p < 0.0001).  
Follow-up paired t-tests showed that thresholds were significantly higher before 
stroke than they were two days after the bilateral V1 lesion (t(15) = 2.455, p = 
0.0268).   
Significant differences between contralateral and ipsilateral side were also 
apparent with unpaired follow-up t-tests.  After the bilateral lesion, significance 
occurred between ipsilateral and contralateral sides 2D after stroke induction 
(t(14) = 3.135, p = 0.0073), 1W after (t(14) = 3.090, p = 0.0080), as well as 2W 
after (t(14) = 3.472, p = 0.0037).  These were the only significant differences 
found in this group, as are shown in Figure 6. 
Experienced Rats - MCAo and V1 Lesions - Full Field SF Thresholds 
 As has been described previously (Silver, 2003), and as is shown in Figure 
7, animals’ full field SF threshold measures increased from P15 to P30 through 
both eyes with daily VOS testing (M = 0.269 ± 0.002, and M = 0.833±, M = 0.832 
± 0.002).  Full field SF thresholds were also significantly greater for P15-P30 
enhanced animals in adulthood than for adult controls, which did not receive 
developmental (P15-P30) visual experience (M = 0.832 ± 0.002 vs. M = 0.529 ± 
0.002, t(9) = 525.149, p < 0.0001).   
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Repeated measures ANOVA revealed a significant interaction for the full 
visual field SF thresholds of animals with both MCA occlusion and V1 lesions 
(F(1, 9) = 2752.295, p < 0.0001).  Follow-up paired t-tests showed that there was 
not a significant effect of MCA occlusion at any time point.  However, the 
difference between pre-stroke/post experience thresholds and post V1 lesion 
thresholds were significant at all testing times (2D post unilateral V1: t(9) = 
3.010, p = 0.0147; 1W post unilateral V1: t(9) = 3.010, p = 0.0147; 2W post 
unilateral V1: t(9) = 3.009, p = 0.0147; 2D post bilateral V1: t(9) = 101.040, p < 
0.0001; 1W post bilateral V1: t(9) = 93.123, p < 0.0001; 2W post bilateral V1: 
t(9) = 95.852, p < 0.0001), with pre-stroke measures being significantly higher 
than those obtained post-stroke.  Other significant differences were apparent 
between testing sessions 2D post unilateral V1 lesion and all three post-bilateral 
lesion points (2D post bilateral V1: t(9) = 2.896, p = 0.0177; 1W post bilateral 
V1: (t(9) = 2.885, p = 0.0180; 2W post bilateral V1: t(9) = 2.884, p = 0.0181), as 
well as between both 1W and 2W post unilateral V1 lesion, and all three post 
bilateral V1 lesion testing sessions (1W post unilateral V1 vs. 2D post bilateral 
V1: t(9) = 2.431, p = 0.0379; 1W post unilateral V1 vs. 1W post bilateral V1: t(9) 
= 2.927, p = 0.0168; 1W post unilateral V1 vs. 2W post bilateral V1: t(9) = 2.916, 
p = 0.0172; 2W post unilateral V1 vs. 2D post bilateral V1: t(9) = 2.440, p = 
0.0374; 2W post unilateral V1 vs. 1W post bilateral V1: t(9) = 2.938, p = 0.0165; 
2W post unilateral V1 vs. 2W post bilateral V1: t(9) = 2.927, p = 0.0168), again 
suggesting that thresholds were greatly reduced following stroke.  These 
differences are represented in Figure 9, and lesion boundaries in Figure 8.   
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Unpaired t-test follow-ups unveiled a significant difference between 
contralateral and ipsilateral thresholds at 2D (t(9) = -193.118, p < 0.0001 ), 1W 
(t(8) = -110.059, p < 0.0001), and 2W post unilateral V1 lesion (t(8) = -102.792, p 
< 0.0001), suggesting that the first V1 lesion reduced the contralateral visual field 
threshold, and that the induction of the bilateral V1 lesion evened out OKT 
thresholds in both directions.  These differences are also shown in Figure 9. 
Experienced Rats - MCAo and V1 lesions - Monocular Field SF Thresholds 
There was a significant interaction, exposed by repeated measures 
ANOVA, for the monocular field SF threshold data of developmentally 
experienced animals (F(1, 9) = 6.762, p < 0.0001).  Follow-up paired comparisons 
show no significant differences between the SF threshold measures at each testing 
session.   
Unpaired t-tests showed that the only significant difference between sides 
(contralateral vs. ipsilateral) was apparent at 2D after unilateral V1 lesions (t(8) = 
-2.712, p = 0.0266).  This difference is small, and suggests a minor deviation from 
pre-stroke thresholds contralateral to a unilateral stroke, but this difference is no 
longer apparent one week after the lesion, as is shown by Figure 10.     
Normal vs. Experienced Rats - MCAo and V1 lesions - Full Field SF Thresholds 
With data collected using repeated measures ANOVA, a significant 
interaction was apparent between group, side, and full field thresholds when 
comparing experienced and normal rats (F(1, 9) = 1559.099, p < 0.0001).  
Follow-up unpaired t-tests showed that developmentally experienced animals’ 
OKT thresholds were significantly higher than controls (t(16) = 242.863, p < 
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0.0001), which also showed that this enhancement raised OKT thresholds to 
levels significantly higher than animals with no such experience.  This difference 
between the two groups remained significant after MCAo, as this procedure did 
not affect OKT thresholds.  Differences between groups were significant at all 
times after unilateral V1 stroke (2D post unilateral V1: t(24) = 3.547, p = 0.0016; 
1W post unilateral V1: t(24) = 3.600, p = 0.0014; 2W post unilateral V1: t(24) = 
3.604, p = 0.0014), though these differences disappeared after the bilateral V1 
stroke (2D post bilateral V1: t(24) = -1.167, p = 0.2546; 1W post bilateral V1: 
t(24) = -1.443, p = 0.1620; 2W post bilateral V1: t(24) = -1.327, p = 0.1969), 
which showed that the enhanced animals’ thresholds were significantly higher 
than controls, and following V1 lesions were reduced from values far above 
controls (M = 0.837 ± 0.003), to values very similar to V1 damaged controls (M = 
0.508 ± 0.009).  This portion of the data illustrated how the enhancement was 
removed completely with damage to V1 (Figure 11).   
Experienced Rats - V1 Lesions - Full Field SF Thresholds 
A significant interaction was present for the full field SF threshold data of 
experienced animals with V1 lesions only (F(1, 6) = 3898.250, p < 0.0001).  
Follow-up paired t-tests showed that thresholds were significantly reduced after 
V1 stroke, and the difference between pre-stroke thresholds and all post stroke 
thresholds were significant (2D post unilateral V1: t(9) = .2999, p = 0.015; 1W 
post unilateral V1: t(9) = .2998, p = 0.015; 2W post unilateral V1: t(9) = .2998, p 
= 0.015, 2D post bilateral V1: t(9) = 115.493, p < 0.0001; 1W post bilateral V1: 
t(9) = 96.472, p < 0.0001; 2W post bilateral V1: t(9) = 88.393, p < 0.0001).   
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Follow-up unpaired t-tests revealed a significant difference between the 
contralateral and ipsilateral side at all times within the unilateral lesion 2 week 
period (t(8) = -95.763, p < .0001; t(8) = -74.367, p < .0001; t(8) = -74.333, p < 
.0001), just before the bilateral lesion.  These differences suggest that there was 
an initial significant decrease in the visual field contralateral to the first lesion.  
After the bilateral lesion the SF threshold of the opposite visual field came down 
to the level of the first affected visual field, and therefore they were no longer 
significantly different (see Figure 13; for lesion boundaries, see Figure 12). 
Experienced Rats - V1 lesions – Monocular Field SF Thresholds   
As can be seen in Figure 14, repeated measures ANOVA did not disclose 
a significant interaction for monocular field SF thresholds of V1 stroke animals 
(F(1, 6) = 2.104, p = 0.070).  No further follow-up tests were completed on these 
data. 
Normal vs. Experienced Rats - V1 lesions – Full Field SF Thresholds 
The overall trends in OKT threshold changes were similar between 
experimental animals and controls, although the differences were much greater 
for experimental animals (Figure 15).  Repeated measures ANOVA was used to 
compare experimental groups and control groups.  A significant interaction was 
apparent between group, side, and full field thresholds (F(1, 6) = 3101.742, p < 
0.0001).  Follow-up unpaired t-tests confirmed a significant difference between 
developmental visual experienced animals and controls prior to stroke induction 
(t(24) = 402.998, p < 0.0001), providing further evidence that P15-P30 testing 
does significantly enhance full field OKT thresholds beyond that of a naïve 
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animal.  Following unilateral V1 devascularization, differences between the 
groups remained significant (2D post unilateral V1: t(24) = 3.544, p = 0.0017; 1W 
post unilateral V1: t(24) = 3.592, p = 0.0015; 2W post unilateral V1: t(24) = 
3.606, p = 0.0014), albeit to a much lesser degree.  After the bilateral V1 stroke, 
thresholds were no longer significantly different between the two groups which 
demonstrated further the sizeable reduction in enhanced animals’ thresholds 
compared to controls.  Experience enhanced animals thresholds were far above 
normal inexperienced animals prior to stroke (M = 0.834 ± 0.002 vs. M = 0.529 ± 
0.002, respectively), and were reduced to the same level as normal animals after 
damage to V1 (Experienced: M = 0.511 ± 0.010 vs. Normal: M = 0.511 ± 0.005).    
Summary 
 The first objective of this study was to determine the effects of stroke on 
visuomotor behaviour in normal animals.  These data show that MCAo did not 
affect normal animals’ OKT thresholds.  However, there was a significant 3% 
decrease in full field SF thresholds following visual cortex stroke.  Silver (2003) 
found no such decrease in OKT thresholds after aspiration lesion, providing 
further evidence for the finding that aspiration lesions do not cause the same 
effects as other stroke models in rodents (Gonzalez & Kolb, 2003; Forgie, Gibb, 
& Kolb, 1996).     
A second objective of this study was to determine if association areas of 
the cortex may be involved in OKT enhancement.  Thresholds obtained from 
experimental animals with developmental visual experience show no effect of 
cortical damage from MCAo, on OKT thresholds.  These data suggest that the 
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MCA territory is not involved in the developmental induced enhancement of OKT 
behaviour.  However, MCAo is known to have an effect on other tests of function 
such as reach training and beam walking (Gharbawie, Gonzalez, Williams, Kleim, 
& Whishaw, 2005) therefore it is important to ensure that the test of function is 
sensitive to the manipulations being made.  Though the OKT test holds promise 
for detecting plastic changes in the visual cortex, this experiment suggests that it 
is not sensitive to lateral MCA territory cortical damage when developmental 
visual experience causes changes in behaviour. 
The effects of sequential V1 lesions in absence of MCA occlusion were 
the same as the effects seen in animals with MCA occlusion followed by V1 
lesions.  That V1 lesion outcome does not differ when preceded by MCA 
occlusion suggests that the enhancement that occurs following developmental 
experience in the form of P15-P30 OKT testing does not rely on communication 
between cortical MCA territory and visual areas, and that Silver’s (2003) original 
hypothesis that P15 enhancing takes place solely in the visual cortex has not been 
disproved.  However, this may be the case only for visual experience, and I will 
return to this topic in upcoming chapters.   
 The main objective of this study was to determine the effects of 
developmental experience on OKT thresholds after a stroke.  The above data 
shows that plasticity and enhancement that occurs in infancy has long lasting 
effects into adulthood, and can also affect functional outcome after cortical 
damage in adulthood.  Developmentally enhanced animals showed a differential 
loss of function when compared to animals that were not subject to visual 
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experience.  A 60% decrease in OKT was apparent in experienced animals, which 
is significantly greater than the 3% decrease seen in controls.  These data suggest 
that early life experiences, which result in greater functioning than in naïve 
laboratory animals, may actually increase the relative severity of functional losses 
that accrue after stroke damage in adulthood.  It also shows that there is a 
differential effect of experience, or lack of experience, on stroke outcome.  
Monocular visual field data revealed only one minor significant difference 
one week after the unilateral lesion.  Because this difference was apparent at no 
other testing time, it is likely caused by short term effects of surgery, and does not 
represent a permanent change in monocular visual field OKT thresholds.  On the 
other hand, it may also be the case that minor changes do occur in the monocular 
visual fields, but that they are much less consistent, and much more difficult to 
detect with statistical significance.  Further investigation of the monocular visual 
fields is necessary to make an imperative conclusion about the effect seen here. 
Overall, this experiment provides evidence to show that 1) visual cortex 
stroke reduces OKT thresholds in the full visual field, 2) association areas of the 
cortex are not involved in the production of normal OKT, or in developmental 
visual experience-induced changes in OKT thresholds, and 3) further evidence 
showing that plastic changes in the visual cortex are linked to the enhancement of 
OKT resulting from developmental visual experience.  A final conclusion that can 
be made from these data is that individual differences in experience can and do 
affect outcome after stroke, in that the amount of functional loss after stroke 
appears to vary depending on pre-stroke experiences.  Developmental experience 
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in rodents affects stroke outcome in adulthood differently than in animals without 
such experience.  
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Chapter 3 – Effects of Stroke in Rats With Adulthood Motor Experience 
3.1 Enhancing OKT With Adulthood Motor Experience 
 The previous chapter showed that visual cortex stroke has a small effect 
on normal function, and that developmental visual experience has a different 
effect on stroke outcome than typical laboratory experience in rats.  It is possible 
that there may be something specific about developmental experience that has 
caused these reported effects, and that different experiences at various times 
throughout the lifespan may not show similar results.  In addition, the experience 
was the same as the measure, and therefore the specificity of the experience may 
be related to the significance of the effects.  To show that it is not just 
developmental experience, or some factor specific to the task which caused a 
change in OKT behaviour following stroke, it is necessary to test stroke outcome 
using a different form of experience all together.      
 It is well known that plasticity occurs in the adult brain as well as in the 
developing brain (Kleim & Jones, 2008; Cheetham, Hammond, Edwards, & 
Finnerty, 2007; Karmarkar & Dan, 2006; Hofer, Mrsic-Flogel, Bonhoeffer, & 
Hubener, 2006; Monfils, Plautz, & Kleim, 2005).  To test that this model is 
sensitive to other forms of plasticity inducing experience, a non-visual adulthood 
experience was used.  The effects of this new type of experience may show that 
this model can be applied to plasticity and experience more generally.     
The following study aims to assess the effects of adulthood motor 
experience, in the form of skilled reaching, on stroke outcome.  Single pellet 
reach training, one form of skilled reaching, is a good motor task candidate for 
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testing the effects of adulthood motor experience on stroke outcome for many 
reasons.  First, it is not a highly visual task, and vision is apparently not a 
requirement to reach success (Whishaw & Tomie, 1989).  In Whishaw’s (1989) 
study, vision was completely occluded using eye patches, and these animals’ 
success in reaching was not impaired.  The following study also provides similar 
conclusions, as animals that have area V1 removed can successfully reach for and 
obtain food pellets.  Secondly, previous unpublished data from this lab, and from 
collaborations with others, have also shown that skilled reaching has an enhancing 
effect on OKT behaviour, similar to changes seen in developmental visually 
enhanced rats.  Normal adult rats raised in standard shoebox cages until 
adulthood, which are then exposed to single pellet reach training show a 
significant 11% enhancement of OKT full field SF thresholds (Alam et al., 2008).  
Thirdly, skilled reaching has been shown to be significantly affected by MCA 
occlusion, the most common form of stroke (Gharbawie, Auer, & Whishaw, 
2006; Gharbawie, Gonzalez, & Whishaw, 2005a; Gharbawie, Gonzalez, 
Williams, Kleim, & Whishaw, 2005b).  In the following experiment, using skilled 
reach training in adult rats, changes in OKT thresholds following this experience 
will be characterized, and the effects of stroke on OKT thresholds will be 
examined.    
The enhancing effect that a motor task, such as skilled reaching, has on 
OKT behaviour leads to the prediction that the brain may be drawing from 
plasticity in areas outside of the visual cortex.  These tasks are thought to involve 
mainly motor areas, and are commonly used as measures of motor function.  The 
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enhancement caused by these tasks, therefore, can be expected to take advantage 
of motor-visual or visual-motor connections.  Because damage that results in 
decreased success in reaching tasks is located in motor and association areas 
(Gharbawie et al, 2005a; Gharbawie et al, 2005b) these cortical areas may be 
involved in the enhancement of OKT caused by skilled reaching.  As was 
mentioned in Chapter 2, OKT has both a visual and motor aspect, and so motor 
association areas of the cortex may also be involved in this form of enhancement.  
Nevertheless, the previous experiment revealed no effect of damage to motor and 
association areas disturbed by MCA occlusion, so an investigation of both motor 
and association cortex damage and visual cortex damage will again be completed.       
3.2 Effects of Two Models of Stroke on OKT Thresholds 
This experiment tests the hypothesis that reach training experience has 
distinct effects on visuomotor outcome following stroke.  In order to test this, rats 
were be subjected to reach training in adulthood, and OKT thresholds were 
obtained following experience, and following stroke.  This experiment revealed 
that visoumotor behaviour is differentially affected by adulthood motor 
experience.     
Methods   
Animals were housed and handled according to Canadian Council on 
Animal Care (CCAC) standards and under the supervision of the University of 
Lethbridge Animal Care Committee. 
Eleven Long Evans (LE) hooded rats were used in this experiment, 8 
males and 3 females, plus 12 age-matched male controls.  All animals were bred 
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in the Canadian Centre for Behavioural Neurosciences (CCBN) vivarium, with 
original stock obtained from Charles River.  The animals were housed in 
polycarbonate cages (45.5cm L x 25.5cm W x 20cm H) in the colony room, 
which was maintained at an ambient temperature of 21 degrees Celsius and 35% 
relative humidity, with a light/dark cycle of 12/12.  The animals had access to 
food and water ad libitum until the beginning of reach training.  
Experience/Single Pellet Reach Training 
Apparatus 
 Single pellet reaching boxes were made of clear Plexiglas (40cm x 45cm x 
13.1cm).  Animals are trained to reach through a small vertical opening 1.3cm 
wide x 15cm high.  A 4cm wide platform to place the food pellets on is attached 
to the outside of the opening, 4cm above the floor.  Two small indentations, 5mm 
in diameter and 1.5mm deep are evenly spaced in line with the edges of the 
vertical opening.  This placement encourages the animals to use only their 
preferred paw, since they will have to reach across their midline to obtain the 
pellet.  They will be much less successful at obtaining a pellet if it is placed on the 
same side as their preferred paw.    
Food Deprivation 
 Two days before the commencement of single pellet reach training, food 
hoppers were removed from the animals’ cages, and from this point on they were 
given a pre-determined amount of food each day.  Food deprivation started with 
animals receiving 30g/d for males, and 25g/d for females (slightly above the 
average daily intake for Long Evans rats).  However, for most animals, this 
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amount was too much to consume in a day (there was still food remaining in their 
cages at testing time the following day), and their ability to learn the task was 
influenced.  Therefore, after 3 days of reach training at 30g/d or 25g/d, animals 
were permitted only 25g/d for males and 20g/day for females.  This amount of 
food kept their body weight at 95%-100% of free-feeding weight or greater for 
younger animals.  
Training     
 For the first 2 days of training, animals were placed in the reaching 
apparatus with pellets scattered both inside the reaching box and on the reaching 
platform.  On day 3, pellets were placed only on the platform, and the paw which 
the animal chose to reach with more often (the preferred paw) was observed and 
recorded.  If the preferred paw was still unclear at day 3, an additional day was 
used to determine the preferred paw with confidence.  Once the preferred paw had 
been determined, pellets were placed only on the side of the platform opposite 
that paw.  By the 5th or 6th day of reaching, only a single pellet was placed on the 
platform, opposite the animal’s preferred paw.  A pellet was also occasionally 
placed at the back of the reaching box, so that animals would travel to the back of 
the box to reset after each reach attempt.  By day 7 of training, animals were 
familiar with the task, and scoring of the reach attempts began.  Scoring consisted 
of noting the number of “hits”, that is, successful reach attempts where the animal 
reached for a pellet, grasped it, and immediately ate it.  Each animal was given 20 
attempts per session, and percent success was determined.  Once animals reached 
50% success or greater (they successfully retrieved a pellet 50 percent of the time 
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or more) they were considered fully trained in the task.  Reach training was 
continued throughout the experiments, with animals getting one to two days rest 
without reaching per week.  Reaching experience was continued throughout the 
study, as it is not yet known if the OKT changes caused by reach training are 
permanent.  If it is not, changes in OKT may have been due to the cessation of 
reaching.  
OKT Testing 
 Animals were placed in the VOS system for approximately 30-45 minutes 
for each testing session in adulthood.  Full visual field SF and contrast sensitivity 
thresholds and monocular visual fields’ SF and contrast sensitivity thresholds 
were obtained.  Testing took place the day prior to stroke induction and again at 
three time points after each stroke induction; two days post-stroke, one week post 
stroke, and two weeks post stroke.  SF threshold measurements were randomly 
double-checked by an outside observer. 
Stroke Models 
MCAo 
 A permanent occlusion model was used for MCA stroke in this study, as 
described earlier.  Briefly, animals were anesthetized with 2% isofuorane 
evaporated in 1.5L/min oxygen.  An incision was made from the chest bone 
rostrally approximately 1.5cm, and the underlying was gently separated using a 
saline dampened swab and the carotid artery was isolated.  The animal was then 
moved to the stereotaxic apparatus, where a midline incision was made, 
approximately 1.5 cm in length.  A #11 scalpel was used to detach the muscle 
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from the sagittal ridge and an opening was drilled approximately 1mm anterior to 
bregma to approximately 5mm posterior to bregma, and extended from the 
mandible, to 4 mm dorsal to the mandible.  The dura was gently removed, and 
current conducting tweezers were then used to coagulate the MCA.  Both carotids 
were clamped with micro-aneurysm clamps (ROBOZ) for 30 minutes after which 
the clamps were removed and both incisions were sutured with standard suture 
material.  Polysporin was applied to the incisions to aid healing, and 1ml Saline 
and 0.03ml buprinex (torbusec) were administered subcutaneously.  Animals were 
given food and water ad libitum for while their recovery was being monitored and 
were returned to their home cages in the colony room after 24 hours. 
V1 Pial Strip 
 V1 devascularization was completed as described earlier.  An opening was 
made in the skull from 6mm to 12mm posterior to bregma, and from 1mm lateral 
to bregma to the sagittal ridge (Paxinos and Watson, 1998).  The underlying dura 
was carefully peeled off and a cotton swab dampened with saline was used to 
wipe the vasculature off of the exposed brain surface.  The incision was then 
sutured closed and animals were given 0.03ml of buprenorphine (torbusec) and a 
1ml injection of saline subcutaneously.  Food and water were available to the 
animals ad libitum while their recovery was being monitored and were returned to 
their home cages after 24 hours. 
Histology 
As described in the previous experiment, animals were sacrificed to verify 
lesion location and size by an intraperitoneal injection of 0.7ml Euthansyl.  
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Animals were then perfused with 1% buffered saline and 4% paraformaldehyde, 
and brains were kept in 4% paraformaldehyde for 48 hours, and then in 30% 
sucrose solution until slicing.  Digital pictures were taken before slicing for 
quantification of the surface features and lesion boundaries.  After slicing, the 
brains were stained using Cresyl Violet to view the depth of the damage.   
Statistical Analyses 
Repeated measures analysis of variance (ANOVA) was used to analyze 
the SF thresholds at each testing time (Statview, Version 5.0.1.0, SAS Institute 
Inc.).  Follow up paired t-tests were used to analyze between testing sessions data 
and unpaired t-tests were used to compare within testing session effects 
(comparisons between contralateral and ipsilateral eye).  The alpha level for this 
experiment was set at 0.05.  
Results 
 There was no effect of MCA occlusion on OKT thresholds.  Statistical 
analyses also revealed that V1 devascularization significantly reduced full visual 
field OKT thresholds in all groups. 
Experienced Rats - MCAo and V1 lesions - Full Field SF Thresholds 
By means of repeated measures ANOVA, a significant main effect of 
testing time was evident (F(1, 10) = 405.024, p < 0.0001) as well as a significant 
interaction between testing time and side (contralateral/ipsilateral) (F(1, 10) = 
125.936, p < 0.0001) for single pellet reach trained rats with both MCAo and 
sequential V1 devascularization (see Figure 17 for reaching success data).  
Follow-up paired t-tests showed that single pellet reach training significantly 
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enhanced OKT thresholds (t(11) = -110.689, p < 0.0001).  There was no effect of 
MCA occlusion at any time; therefore, measures taken after reach training are 
essentially the same as after MCA occlusion, and the MCA occlusion testing will 
be omitted from the remainder of this analysis.  Further significant differences 
were apparent between post-reach training measures and all post V1 lesion 
measures (2D post unilateral V1: t(11) = 3.613, p = 0.0041; 1W post unilateral 
V1: t(11) = 3.692, p = 0.0036; 2W post unilateral V1: t(11) = 3.628, p = 0.0040; 
2D post bilateral V1: t(11) = 17.768, p < 0.0001; 1W post bilateral V1: t(11) = 
27.421, p < 0.0001; 2W post bilateral V1: t(11) = 27.004, p < 0.0001), evidence 
that OKT thresholds did not recover to post-reaching values, and that V1 stroke 
significantly decreased thresholds from post-reach training levels.  OKT 
thresholds observed 2D after the unilateral V1 lesion were significantly different 
from those 2D after the bilateral lesion (t(11) = 2.698, p = 0.0207), 1W after the 
bilateral lesion (t(11) = 2.408, p = 0.0347), and 2W after the bilateral lesion (t(11) 
= 2.356, p = 0.0381).  Thresholds recorded 1W after the unilateral lesion were 
significantly different from all three post-bilateral lesion testing sessions (2D post 
bilateral V1: t(11) = 2.651, p = 0.0224; 1W post bilateral V1: t(11) = 2.370, p = 
0.0371; 2W post bilateral V1: t(11) = 2.317, p = 0.0408) as well as from 2W after 
the unilateral lesion (t(11) = -2.259, p = 0.0452).  Two weeks subsequent to the 
unilateral lesion, OKT thresholds remained significantly different from those 
obtained after the bilateral lesion as well (2D post bilateral V1: t(11) = 2.990, p = 
0.0123; 1W post bilateral V1: t(11) = 2.697, p = 0.0208; 2W post bilateral V1: 
t(11) = 2.647, p = 0.0227).  These data showed that SF thresholds were 
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significantly reduced contralateral to the each V1 lesion.  Lesion boundaries are 
presented in Figure 16.   
Similar to previous data, significant differences between the contralateral 
and ipsilateral visual fields were only apparent, using unpaired t-test follow-ups, 
at 2D (t(10) = 17.107, p < 0.0001), 1W (t(10) = 18.237, p < 0.0001), and 2W 
subsequent to the unilateral V1 lesion (t(10) = 16.537, p < 0.0001).  These data 
are represented in Figure 18, and show that thresholds were significantly reduced 
contralateral to the unilateral V1 lesion, and that following the bilateral lesion, the 
opposite visual field’s thresholds were reduced to similar levels as the initially 
affected side.   
Experienced Rats - MCAo and V1 lesions- Monocular Field SF Thresholds 
Data collected for monocular visual field SF thresholds did not show a 
significant interaction when analyzed with repeated measures ANOVA (F(1, 10) 
= 0.952, p = 0.4902). Once again, MCA occlusion had no effect on OKT 
thresholds at any time point (as presented in Figure 19).           
Normal vs. Experienced Rats -  MCAo and V1 lesions - Full Field SF Thresholds 
Comparisons of normal and experienced animals, using repeated measures 
ANOVA, revealed a significant interaction between side, group, and SF threshold 
measures (F(1, 10) = 139.448, p < 0.0001).  Follow up unpaired t-tests showed 
that prior to experience or stroke, the experimental and control groups’ full visual 
field OKT thresholds were statistically the same (t(18) = -0.091, p = 0.9287).  
Differences between SF thresholds of the two groups after reach training, 
however, were significant which suggested that reach training significantly 
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enhanced OKT thresholds above control thresholds (t(18) = 78.330, p < 0.0001).  
This difference was apparent at all testing times after MCA occlusion as well 
(t(18) = 91.111, p < 0.0001), as this procedure had no effect on OKT thresholds.  
At each testing session after unilateral V1 stroke, experimental and control groups 
remained significantly different from each other (2D post unilateral V1: t(26) = 
3.619, p = 0.0013; 1W post unilateral V1: t(26) = 3.576, p = 0.0014; 2W post 
unilateral V1: t(26) = 3.999, p = 0.0005), due to the much increased thresholds of 
the non-affected ipsilateral visual field.  Following the bilateral lesion, significant 
differences between the groups disappeared, as their thresholds were now very 
similar.  These data showed that the overall pattern of OKT disruption was similar 
between control groups and experimental groups however, the magnitude of the 
loss was much greater for the enhanced animals, as can be seen in Figure 20.     
Experienced Rats - V1 Lesions - Full Field SF thresholds 
Repeated measures ANOVA demonstrated a significant main effect of 
testing time (F(1, 7) = 125.823, p < 0.0001) and a significant interaction between 
testing time and contralateral or ipsilateral side (F(1, 7) = 108.523, p < 0.0001) in 
animals with only sequential V1 lesions.  Follow-up paired t-tests show that reach 
training significantly enhanced OKT from pre-experience levels (t(15) = -36.729, 
p < 0.0001), and that all post-lesion testing times showed thresholds that were 
significantly reduced from those obtained after reach training (2D post unilateral 
V1: t(15) = 3.664, p = 0.0023; 1W post unilateral V1: t(15) = 3.590, p = 0.0027; 
2W post unilateral V1: t(15) = 3.572, p = 0.0028; 2D post bilateral V1: t(15) = 
16.954, p < 0.0001; 1W post bilateral V1: t(15) = 18.649, p < 0.0001; 2W post 
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bilateral V1: t(15) = 19.302, p < 0.0001).  Animals’ thresholds did not return to 
reach training enhanced levels.  Thresholds did, however, remain close to pre-
reaching values after the V1 lesions, as only marginally significant differences 
were apparent between pre-reaching thresholds and post lesion thresholds.  This 
suggested that the reach training enhancement was removed with V1, and 
although the animals’ thresholds were slightly lower than at initial baseline testing 
before experience, they were much closer to naive values than to post-reach 
training values.  Following the induction of the bilateral V1 lesion, significant 
differences existed between 2D post unilateral V1 lesion and 2D post bilateral 
lesion (t(15) = 2.590, p = 0.0205), 2D post unilateral V1 lesion and 1W post 
bilateral lesion (t(15) = 2.515, p = 0.0283), as well as between 2D post unilateral 
V1 lesion and 2W post bilateral lesion (t(15) = 2.422, p = 0.0286).  The testing 
session at 1W after the unilateral V1 lesion was also significantly different from 
the post bilateral times (2D post bilateral V1: t(15) = 2.565, p = 0.0215; 1W post 
bilateral V1: t(15) = 2.490, p = 0.0250; 2W post bilateral V1: t(15) = 2.396, p = 
0.0300), as was the testing session at 2W post unilateral lesion (2D post bilateral 
V1: t(15) = 2.783, p = 0.0139; 1W post bilateral V1: t(15) = 2.713, p = 0.0160; 
2W post bilateral V1: t(15) = 2.621, p = 0.0193).  These data showed that 
thresholds obtained after the V1 lesions were significantly reduced from pre-
lesion thresholds   
Unpaired t-test follow ups also revealed significant differences between 
contralateral and ipsilateral visual fields at all three testing sessions subsequent to 
the unilateral V1 lesion but prior to the bilateral lesion (2D post unilateral V1: 
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t(14) = -18.483, p < 0.0001; 1W post unilateral V1: t(14) = -22.795, p < 0.0001; 
2W post unilateral V1: t(14) = -16.136, p < 0.0001).  These differences show that 
the OKT thresholds of the visual feild contralateral to the unilateral V1 lesion 
were significantly reduced.  Following the bilateral lesion, the thresholds 
measured through the other eye were then reduced to similar levels, and 
thresholds had evened out.  The above data are represented in Figure 22, along 
with lesion boundaries for this group in Figure 21. 
Experienced Rats - V1 lesions - Monocular Field SF Thresholds  
As can be seen in Figure 23, data for the monocular visual fields did not 
show any significant differences, as repeated measures ANOVA revealed no 
significant main effect (F(1, 7) = 2.074, p = 0.0534), or interaction (F(1, 7) = 
0.176, p = 0.9895).  
Normal vs. Experienced Rats V1 lesions – Full Field SF Thresholds 
Data comparing normal rats with reach trained rats are represented in 
Figure 24.  These data showed that the overall pattern of OKT disruption was 
similar between control groups and experimental groups.  However, the 
magnitude of the loss was much greater for the enhanced animals.  Using repeated 
measures ANOVA a significant interaction was apparent between side 
(contralateral: ipsilateral), group (experimental: controls) and full field OKT 
thresholds at each testing time (F(1, 7) =53.704, p < 0.0001).  Unpaired t-test 
follow-up analyses showed that experimental and control thresholds were not 
different before experience or lesions (t(30) = -0.504, p = 0.6178).  After reach 
training, however, the groups’ OKT thresholds did become significantly different 
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(t(30) = 38.857, p < 0.0001), with the reach trained animals now showing much 
higher thresholds than controls.  After unilateral V1 lesions, the groups’ 
thresholds remained statistically different from each other at all three testing times 
(2D post unilateral V1: t(30) = 2.798, p = 0.0089; 1W post unilateral V1: t(30) = 
2.776, p = 0.0094; 2W post unilateral V1: t(30) = 3.001, p = 0.0054) due to the 
unaffected ipsilateral side.  This trend was abolished after the bilateral lesion, 
when both groups’ thresholds were reduced to the same level, and no longer 
differed significantly (2D post bilateral V1: t(30) = 1.075, p = 0.2907; 1W post 
bilateral V1: t(30) = 1.387, p = 0.1756; 2W post bilateral V1: t(30) = 1.737, p = 
0.0927), which suggested that the experimental groups’ thresholds were decreased 
much more than controls, as they were significantly higher to begin with.  
Overall, animals from the experimental group suffered a much greater reduction 
of OKT thresholds than the control group. 
Summary 
 The above data shows how full field SF thresholds and monocular field SF 
thresholds are affected by MCA occlusion and sequential V1 lesions in rats with 
adulthood motor task experience.  Animals’ full field SF thresholds are 
significantly increased by 11% after single pellet reach training, further evidence 
that this experience enhances OKT.  Following MCA occlusion, no changes were 
seen in OKT thresholds, suggesting that the cortical areas damaged by MCA 
stroke are not involved in OKT or its enhancement with skilled reaching.  MCAo 
did reduce reaching success (Figure 17), however, showing that MCAo does 
interfere with circuitry involved in skilled reaching.  After visual cortex lesions, 
 56
full field SF thresholds dropped 12%, to levels similar to those of normal animals 
following V1 stroke.  V1 lesions, therefore, appear to abolish the experience-
induced enhancement related to reach training.  Due to these findings, the 
involvement of visual cortex in skilled reaching may be greater than previously 
assumed, and the visual cortex may be involved in sensory integration necessary 
for successful reaching.  
With respect to the effect that experience has on behavioural function after 
stroke, the above study provides further evidence to support the hypothesis that 
experience affects the behavioural outcome observed after a stroke.  It appears 
that experience in adulthood results in plastic changes in the brain which change 
baseline function.  This change in baseline function subsequently results in 
differential behavioural outcomes after stroke.   
In experiment 1 developmental visual experience resulted in a 60% 
reduction in OKT thresholds, yet in this experiment, only a 12% decrease was 
noted following adulthood motor experience.  This model, therefore, is sensitive 
not only to developmental VOS experience, but can be used to detect plasticity in 
the visual cortex that is linked to experience in a seemingly non-visual task, in 
this case, skilled reaching.       
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Chapter 4 – Effects of Stroke in Rats With Developmental Visual Experience 
and Adulthood Motor Experience 
4.1 Combining Developmental Visual and Adulthood Motor Experience 
The above experiments showed the effects of developmental visual 
experience and adulthood motor experience on stroke outcome as measured by 
OKT.  Developmental visual experience has been shown to enhance OKT 
thresholds by approximately 59%, and following V1 stroke, results in a 
differential loss of function than in normal animals.  Adulthood motor experience, 
on the other hand, has a similar enhancing effect on OKT which is manifested as 
an 11% increase in OKT thresholds, and which is also affected differently than 
normal or developmentally experienced animals after stroke. These two 
experiments then, have shown differential effects of each specific experience on 
stroke outcome.  However, in the natural world, humans and animals are exposed 
to many different experiences throughout life, both during development and in 
adulthood.  Therefore, it is necessary to test the effects of both forms of 
experience combined, on stroke outcome.  
The following experiment aims to combine the above two studies, by 
using both developmental visual experience and adulthood motor experience to 
enhance OKT.  The two previous studies have shown that both forms of 
enhancement are modulated by the visual cortex, as its removal or damage to it 
eliminates enhancement.   
OKT is enhanced by both visual and motor experience, and so there may 
be two pools of plasticity within the visual cortex that can be drawn from, a visual 
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related plasticity, and a motor related plasticity.  If the enhancement that occurs 
with developmental visual experience is essentially the same as that which occurs 
with skilled reaching, then we should see an additive effect of combining 
experiences, or possibly a ceiling effect where the greater of the two 
enhancements cancels out the other.  Previous experiments have shown that when 
animals enhanced through developmental visual experience are subsequently 
monocularly deprived, their SF thresholds can be increased far beyond levels after 
the enhancing experience alone (Prusky, Alam, & Douglas, 2006).  This implies 
that the latter suggestion of a ceiling effect is unlikely at levels following the 
visual experience, since enhancement above developmentally experienced 
thresholds have been shown in monocularly deprived animals.  However, 
deprivation may draw on different mechanisms within the brain than those used 
with experience alone, and therefore results from deprivation studies may not 
apply to experience based studies.      
On the other hand, these two methods of enhancing OKT may be drawing 
from separate areas of plasticity in the brain.  Results may show the same 
behavioural manifestation in this case, either an additive effect of the 
enhancement or again, a cancellation of one of the enhancements.  The results of 
combining both types of enhancement may not reveal the location in the cortex of 
the enhancement, but when experience is combined with the effects of stroke, a 
clearer picture may emerge.   
If there are two plasticity pools being drawn from, different results than 
the previous two experiments should surface following V1 stroke.  There may be 
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a different degree of decrease in OKT thresholds after V1 lesions.  One possibility 
is that there could be an elimination of only one of the enhancements, that is, 
OKT thresholds may reduce to reach training enhanced levels, or if there is an 
additive effect, to developmentally enhanced levels.  This would imply that the 
remaining enhancement is located outside of V1 when experiences are combined.  
However, if the plasticity is truly only present in the visual cortex, as the previous 
studies suggest, we should see a total elimination of all enhancements after V1 
lesion.     
The previous two studies have provided significant evidence to show that 
cortex damaged by MCA occlusion is not involved in OKT production, and that 
V1 removal can eliminate both visual and motor enhancement, so association 
areas will not be damaged in this final study.   
4.2 Effects of Visual Cortex Stroke on OKT Thresholds 
This experiment aims to provide further evidence about the cortical 
location of visual experience enhancement, reach training enhancement, and the 
effect of these experiences combined.  Furthermore, the hypothesis that different 
experience leads to differential behavioural losses after stroke will also be tested.   
Animals will be subject to both developmental and adulthood experiences, and the 
effects of this combination will be investigated following each experience and 
following stroke.  It has been suggested, in these results, that combining different 
experiences in the rat results in differential visuomotor behavioural outcomes 
after stroke.  
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Method 
Animals were housed and handled according to Canadian Council on 
Animal Care (CCAC) standards and under the supervision of the University of 
Lethbridge Animal Care Committee. 
Two male and three female LE hooded rats were used in this experiment 
(N = 5), as well as with 8 age matched male control LE rats.  All animals were 
bred in the Canadian Centre for Behavioural Neurosciences (CCBN) vivarium, 
with original stock obtained from Charles River.  The animals were housed in 
groups of two or three in polycarbonate cages (45.5cm L x 25.5cm W x 20cm H) 
in the University of Lethbridge colony room.  This room was maintained at an 
ambient temperature of 21 degrees Celsius and 35% relative humidity, with a 
light/dark cycle of 12/12.  The animals had access to food and water ad libitum 
throughout the study, until the beginning of food deprivation described shortly.  
Animals were weaned at approximately 22 postnatal days, at which time males 
and females were separated and housed in identical conditions in the colony 
room.   
Experience/P15 enhancing 
 Animals’ thresholds were permanently enhanced as described previously, 
in Chapter 2.  
OKT Testing 
 Animals were placed in the VOS system for approximately 30-45 minutes 
for each testing session in adulthood.  Full visual field SF and contrast sensitivity 
thresholds, and monocular visual field SF and contrast sensitivity thresholds for 
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both sides were obtained in this time.  SF threshold measurements were randomly 
double-checked by an outside blind observer. 
Experience/Single Pellet Reach Training  
Apparatus 
 The same single pellet reaching boxes used in the previous experiment 
were used here as well.  Reaching boxes were made of clear Plexiglas (40cm x 
45cm x 13.1cm) with a vertical opening 1.3 cm wide x 15 cm high.  A 4 cm wide 
platform is attached to the outside of the opening, 4 cm above the floor, with two 
small indentations, 5 mm in diameter and 1.5 mm deep, evenly spaced in line with 
the edges of the vertical opening.   
Food Deprivation 
 Food deprivation commenced two days before training, and as was 
described previously, animals were permitted only 25g/d for males and 20g/day 
for females, keeping their body weight at 95%-100% or greater for younger 
animals.  
Training     
 As was described in Chapter 3, the first 4-5 days of training were used to 
determine paw preference. By day 7 of training, animals were familiar with the 
task, and scoring of the reach attempts began.   
Stroke Model 
V1 Pial Strip 
 V1 pial strip lesions were induced as described earlier, in Chapter 2. 
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 Histology 
 Histological procedures were carried out as described in previous chapters.  
Digital photos were used to determine lesion boundaries, and Cresyl Violet 
staining was used to determine lesion depth. 
Statistical Analyses 
Repeated measures analysis of variance (ANOVA) was used to analyze 
the SF thresholds at each testing time (Statview, Version 5.0.1.0, SAS Institute 
Inc.).  Follow up unpaired t-tests were used to compare within testing session 
effects (comparisons between contralateral and ipsilateral eye), and paired t-tests 
were used to analyze between testing sessions data.  The alpha level for this 
experiment was set at 0.05. 
Results 
 The following data showed that V1 devascularization significantly 
reduced full and monocular visual field OKT thresholds. 
Experienced Rats - V1 Lesions - Full Field SF Thresholds 
Repeated measures ANOVA revealed a significant main effect of testing 
time (F(1, 7) = 23118.746, p < 0.0001), and a significant interaction between 
testing time and contralateral/ipsilateral side (F(1, 7) = 9247.804, p < 0.0001) for 
rats with both developmental and adulthood experience.  Follow-up paired and 
unpaired t- tests were used to further analyze the source of the interaction.  Paired 
comparisons showed that reach training did not enhance OKT thresholds beyond 
visual experience enhancing (t(9) = -1.5, p = 0.1679).  This suggests that visual 
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enhancing is masking the effects of the reach training enhancement, and that the 
reach training enhancement does not occur when visual experience has already 
increased thresholds in the full field.  All post lesion OKT thresholds were 
significantly lower than both pre-reach training and post-reach training thresholds, 
which were equal as was previously mentioned (M = 0.839 ± 0.004 and M = 
0.839 ± 0.004).  When comparing thresholds from 2D after the unilateral V1 
lesion, tests showed that thresholds were significantly higher than 2D and 1W 
post bilateral V1 lesion (t(9) = 2.901, p = 0.0176), as well as 2W post bilateral 
lesion (t(9) = 2.842, p = 0.0193).  OKT thresholds recorded 1W after the 
unilateral lesion were also significantly higher than those obtained 2D (t(9) = 
2.929, p = 0.0168), 1W (t(9) = 2.929, p = 0.0168), and 2W after the bilateral 
lesion (t(9) = 2.869, p = 0.0185).  Similarly, measures obtained 2W after 
unilateral lesion were significantly different also from all three post bilateral 
lesion testing times (2D post bilateral V1: t(9) = 2.978, p = 0.0155; 1W post 
bilateral V1: t(9) = 2.978, p = 0.0155; 2W post bilateral V1: t(9) = 2.918, p = 
0.0171).  These data suggested that although thresholds were reduced after the 
unilateral V1 lesion, they were still higher following the unilateral lesion than 
after the bilateral lesion.  This is due to the fact that the ipsilateral side was 
unaffected until after the induction of the bilateral lesion.  OKT thresholds did not 
revert back to post-experience levels, and after both V1 lesions these thresholds 
were comparable only to those of inexperienced animals. 
Unpaired t-tests showed that differences between the contralateral and 
ipsilateral visual fields were significant at all post unilateral lesion time points, 2D 
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post unilateral lesion (t(8) = -108.757, p > 0.0001), 1W post unilateral lesion (t(8) 
= -102.538, p < 0.0001), and 2W post unilateral lesion (t(8) = -96.503, p < 
0.0001), suggesting again a significant reduction of thresholds after a unilateral 
lesion, and an evening out of both visual field’s thresholds after a bilateral lesion.  
Lesion boundaries and data for this group have been presented in Figure 25 and 
Figure 26 respectively.     
Experienced Rats - V1 lesions - Monocular Field SF Thresholds  
 Monocular visual field SF threshold data, available in Figure 27, was also 
analyzed using repeated measures ANOVA.  A significant main effect of testing 
time was apparent (F(1, 7) = 10.308, p < 0.0001), as well as a significant 
interaction between testing time and side (F(1, 7) = 9.736, p < 0.0001).  Follow-
up paired t-tests showed that reach training did significantly increase OKT 
thresholds from values obtained before reach training (t(9) = -4.247, p = 0.0022), 
a trend that has only been seen with tray reach enhanced animals.  Other 
significant differences arose after reach training, where the testing session 
immediately following training was found to be significantly higher than all post-
lesion testing times (2D post unilateral V1: t(9) = 2.675, p = 0.0254; 1W post 
unilateral V1: t(9) = 3.537, p = 0.0063; 2W post unilateral V1: t(9) = 3.924, p = 
0.0035; 2D post bilateral V1: t(9) = 4.758, p = 0.0010; 1W post bilateral V1: t(9) 
= 4.821, p = 0.0009; 2W post bilateral V1: t(9) = 4.609, p = 0.0013).  These data 
suggested that the animals’ acuities remained the same after visual experience, 
were increased significantly after reach training, and were then significantly 
reduced following damage to V1.   
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 Using unpaired follow-up t-tests, differences between the contralateral and 
ipsilateral sides were apparent at 2D post unilateral lesion (t(9) = -4.394, p = 
0.0023), 1W post unilateral V1 lesion (t(9) = -2.926, p = 0.0191), and 2W post 
unilateral lesion (t(9) = -2.807, p = 0.0230).  This demonstrated that contralateral 
to first V1 lesion, visual field OKT thresholds reduced significantly compared to 
the ipsilateral (unaffected) side and that after the bilateral lesion the unaffected 
side reduced to thresholds similar to the initially affected side.   
Normal vs. Experienced Rats -  V1 lesions - Full Field SF Thresholds 
 Repeated measures ANOVA was used to check for significance between 
experimental and control groups.  A significant interaction was found through this 
analysis (F(1, 7) = 4593.928, p < 0.0001).  Unpaired follow-up t-tests were used 
to compare thresholds between experimental and control groups.  A significant 
difference existed between P15-P30 experienced animals and controls prior to 
reach training, which showed again that this experience did significantly enhance 
OKT thresholds above inexperienced animals’ thresholds (t(24) = 259.296, p < 
0.0001).  After reach training, this difference remained significant as thresholds 
were unchanged in the previously enhanced group (t(24) = 270.009, p < 0.0001).  
Unilateral V1 stroke reduced OKT thresholds significantly contralateral to the 
lesion, as mentioned earlier, but the difference between experimental and controls 
remained significant at all three post-unilateral lesion (t(24) = 3.647, p = 0.0013; 
t(24) = 3.684, p = 0.0012; t(24) = 3.739, p = 0.0010) because these data are 
collapsed across sides.  Similar to previous experiments, the significant difference 
between the two groups was eliminated after bilateral V1 damage (t(24) = -0.321, 
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p = 0.7511; t(24) = -0.935, p = 0.3592; t(24) = 0.124, p = 0.9023), and thresholds 
of experimental animals and controls became statistically the same.  The above 
data showed that experienced animals’ thresholds were significantly higher than 
controls prior to reach training, they remained much higher than controls after 
reach training, were significantly reduced after unilateral V1 lesion, and were 
reduced further to the same level as controls after bilateral V1 lesion.  These last 
data are represented in Figure 28. 
Summary 
 This experiment combined both developmental visual and adulthood 
motor experiences to assess the effects of visual cortex stroke on visuomotor 
behaviour.  The first objective was to determine the effect of combining two 
different and specific experiences.  The second objective was to investigate the 
effects of additive experience on stroke outcome. 
 From the above experiment, the first conclusion may be that combining 
developmental visual experience with adulthood motor experience does not 
increase full field OKT thresholds above developmental visual enhancing levels.  
The developmental enhancement seems to cancel out, or override, the adulthood 
motor enhancement in the full field.   
However, an unexpected finding was made, in that the monocular acuities 
of these animals were significantly enhanced after reach training.  The reason for 
this is unknown, since prior studies have failed to show significant effects in the 
monocular visual field.  It is possible that there are effects for all animals in the 
monocular field, but because it is such a minuscule change, this was the only 
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single pellet study to find it with significance.  It could also be the case that 
combining both types of experience somehow caused the monocular changes.  For 
example, one possibility is that developmental visual experience occupies the 
plasticity available in the region of V1 dedicated to the full visual field or 
binocular visual field, and that the motor experience enhancement was forced to 
move out to monocular visual field representation areas of the cortex.  However, 
the increase in monocular fields was not equivalent to the 11% increase seen in 
the full field in animals with only motor experience, and was in fact much lower, 
at only 1%.  It does not seem that the full extent of motor enhancement was 
relocated to monocular visual field areas.  Damage to V1 eliminated the 
monocular visual field enhancement, and therefore it may be that relocating the 
enhancement to monocular areas of V1 changed the manifestation of the 
enhancement, and therefore the effects of combining experience may also have 
changed the manifestation of plastic changes in the brain.  If developmental visual 
experience uses up the majority of the plasticity in V1, this region may no longer 
have the plastic capacity to allow for further experience to change the brain.  That 
is, plasticity may be limited, and developmental experience may have used the 
majority of the plasticity available.   
 Further conclusions that can be drawn from this study include the finding 
that V1 lesions again eliminate enhancements of OKT caused by experience.  
Animals’ thresholds were reduced to levels similar to normal animals with 
damage to V1, once again.  This provides further evidence to suggest that 
enhancement in OKT thresholds takes place in the primary visual cortex.  Though 
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this experiment did not include MCA occlusion, the finding that enhancement is 
reduced to similar levels as in the two previous studies which did include MCA 
occlusion, make it unlikely that this damage would cause an effect.  There is still 
a possibility that some previously undamaged motor areas may be involved, if 
connections between the visual and motor cortex have been spared with MCA 
occlusion.   
 Results also imply that the plasticity pools, discussed in the introduction to 
this chapter, are combined in the visual cortex.  Because motor experience does 
not increase full field OKT thresholds after visual experience enhancement, it 
seems that the most logical answer is that there is only one plasticity pool located 
in the visual cortex.  The entire full field and monocular field enhancements are 
both removed with the visual cortex, and therefore this must be where the 
plasticity that allows for increased OKT thresholds is located.  If there were 
another, undamaged plasticity pool, one would predict that OKT thresholds would 
not have reduced completely, or at least not to the level of other singly enhanced 
and normal animals, or the monocular enhancement may not have been eliminated 
with V1 damage.   
 With regard to the possibility of a ceiling effect, data is somewhat 
inconclusive.  An additive effect was not noticed in the full visual field, and 
therefore it is possible that a ceiling effect has occurred.  As was mentioned 
earlier, monocular deprivation enhances OKT thresholds beyond that of visual 
experience, and so it was predicted that a ceiling effect would not occur.  
However, as was also mentioned earlier, monocular deprivation and the resulting 
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increase in OKT thresholds may use different mechanisms to cause the 
enhancement.  This is most likely the case, as the studies that have shown 
increases in OKT with monocular deprivation also show that once the deprivation 
is removed, acuities in the two eyes even out to pre-deprivation levels (Prusky et 
al., 2006), and therefore enhancement caused by monocular deprivation is 
temporary in rats, and is likely to rely on different mechanisms than our 
permanent enhancement models.   
Because of the unexpected finding that enhancement moved to the 
monocular visual fields when visual and motor experience were combined, further 
investigation of more focal V1 lesions may reveal differential effects on the two 
enhancements.  Since both enhancements are again removed with V1, a smaller 
lesion which does not abolish the entirety of V1 may reveal an area for visual 
enhancement, and an area for motor enhancement within V1.  Smaller V1 lesions 
may also differentiate binocular regions of V1 from monocular regions.  Further 
investigation of regions within V1 and their role in OKT enhancement is 
warranted.  
 The final conclusion that can be drawn from this study is that experience, 
motor, visual, or both, causes differential effects on behaviour after stroke.  Both 
visual experience and motor experience cause changes in the visual cortex that 
effect normal function and the functional losses after stroke.  It is clear that 
changes occur in the brain in response to experience, and these changes result in a 
differential loss of function after stroke, ie. baseline function changes following 
experience, and subsequent to these changes, the manifestation of stroke becomes 
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different than it would have been without the experience.  This shows that 
variability in stroke outcome is affected by individual differences in experience in 
rats, though the mechanisms involved have not been elucidated here.   
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Chapter 5 - Discussion 
5.1 Summary  
One of the most enigmatic features of stroke is variability.  Variability in the 
location and size of a stroke, a patient’s impairments following stroke, 
“spontaneous” recovery, response to treatment, and many other related factors all 
pose problems for researchers and clinicians in finding viable treatments for 
stroke.  Until such variability is better understood, stroke treatments will 
undoubtedly remain unsatisfactory.  This thesis proposes that one of the major 
factors contributing to variability in stroke may be individual differences in life 
experience.  Through the use of a rat model which evaluates evolutionarily stable, 
reflexive visuomotor behaviours (OKT), the effects of specific developmental or 
adulthood experience have been investigated, as well as cortical regions which 
may be involved in the production of enhanced OKT.   
 The first discovery made in these experiments was that normal animals’ full 
visual field OKT thresholds are significantly affected by V1 cortical lesions.  
Visual cortex stroke in inexperienced cage raised laboratory rats caused a small, 
but significant 3% decrease in OKT thresholds.  Since Silver (2003) found that 
visual cortex aspiration does not affect normal OKT, similar to results of cortical 
inactivation studies (Prusky and Ramoa, 1999), these data suggest that different 
stroke models have differential effects on OKT.   
MCA stroke, however, did not have an effect on OKT thresholds of 
inexperienced animals.  This suggests that structures in the MCA territory are not 
involved in the normal functioning of OKT.     
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A second major finding was that full visual field OKT thresholds were 
significantly increased by experience, and the increase in thresholds consistently 
varied depending on the experience.  This effect has been shown previously for 
developmental (Silver, 2003; Prusky et al., in press) and adulthood experience 
(Alam et al., 2008).  For developmental visual experience, a 58-59% increase in 
OKT thresholds was apparent in this study.  OKT thresholds were increased by 
11% for animals who were exposed to adulthood reach training experience.  This 
implies that OKT thresholds are differentially affected by different experiences.  
Previous data has suggested that the visual cortex is highly susceptible to change 
in response to experience (Hofer et al., 2006: Karmarkar & Dan, 2006), and if 
OKT function is dependent on the visual cortex alone, this may help to explain 
these findings.       
The degree of functional loss following stroke was also distinct, 
depending on the task that animals had experienced.  Developmental visual 
experience in the form of OKT testing resulted in an initial 58-59% increase, 
followed by a 60% decrease in OKT thresholds after V1 stroke.  On the other 
hand, adulthood motor experience in the form of reach training resulted in an 11% 
increase in thresholds, and a 12% decrease after stroke.  These data imply that 
experience changes baseline function, which results in a significant effect on 
stroke outcome.  The size of the effect of stroke apparently differs depending on 
the experience of the animal.  Though the change in baseline function was 
necessary to allow for the subsequent decrease in function following stroke, the 
experience of a laboratory rat is limited, and the increased baseline measure is 
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likely more indicative of “normal” function in wild animals.  Therefore, 
reductions in OKT thresholds following stroke will likely differ from these results 
depending on combinations of prior experience in wild animals, or humans.  This 
model, therefore, is sensitive to the differential effects of specific experiences on 
outcome following stroke.  The effects of experience, however, were apparent 
only in the full visual field: the monocular visual field was not affected by each 
experience separately.   
Monocular visual field OKT thresholds were only significantly affected 
when both developmental visual experience and adulthood motor experience were 
combined.  These data suggest that developmental visual experience may have 
occupied the available full visual field enhancing plasticity in the visual cortex, 
and that experience later in life must then be relocated to monocular field 
representation areas (Schwartz, 1999).  In addition, these data suggest that 
specific experiences alone, or combined, can alter the behavioural manifestation 
of experienced-induced plasticity, and that these changes have a significant effect 
on outcome following stroke. 
5.2  Rat Model of Experience-dependent Variability in Stroke Outcome  
Using OKT as a model for testing functional ability of motion vision after 
experience, and functional loss after stroke has many benefits.  First, OKT is a 
universal response seen in all vertebrate species, and therefore, the probability 
that the effects of stroke on this function will be similar in rodents and humans is 
high.  Since many treatment trials have proven successful in rodent models, yet 
remain unsuccessful in humans, the use of a universal response for testing 
 74
function holds promise for discovering treatment results that will transfer from 
one species to the next.  Secondly, OKT is applicable to everyday life.  OKT is 
essentially a response to visual input, and because humans primarily use vision to 
respond to their environment, this test applies to a response which humans make 
everyday, almost unknowingly.  The third reason that this model is beneficial is 
that obtaining OKT thresholds is relatively quick and easy.  Other methods of 
testing vision, such as visual discrimination and the VWT, take weeks to train 
animals and obtain reliable measurements, and infant animals often do not have 
the capacity to learn the task (Prusky et al., 2002; Douglas et, al., 2005).  The 
VOS test of OKT takes less than 45 minutes to obtain both SF and contrast 
sensitivity thresholds, and no training is necessary since it relies on a reflexive 
response.  Another benefit is that this test is sensitive to the effects of specific 
developmental and adulthood experience.  Each new experience that animals were 
exposed to resulted in different changes in OKT.  Therefore, this test can 
differentiate the effects of specific experience, a valuable characteristic for 
investigating the effects of experience on normal function.  Also, this model has 
shown differential effects of stroke depending on prior experience, and so is not 
only sensitive to the effects of experience, but also to the effects that these 
experiences can have on stroke outcome.  This model also allows for experience 
to be controlled, as laboratory rats have limited life experience and can easily be 
subject to one or only a few novel situations.   
One of the greatest benefits of this model, however, is the promise of 
creating a similar test for humans.  Many virtual reality therapies have been 
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developed, and most could easily be used as a test of OKT (Rose et al., 2005; 
Ansuini et al., 2006).  Since the stimuli used in the VOS test of OKT is simple 
sinusoidal gratings, implementing this stimuli into an already much more complex 
apparatus should be relatively easy.   
There are many directions that this research can follow within the realm of 
animal studies, however, 1) What are the effects of other types of experience? 2) 
Are other motor areas involved, which were not damaged by MCAo? 3) Are there 
specific areas within V1 that are responsible for each enhancement separately? 
First, it has yet to be shown how experiences other than those used in the 
above studies affect OKT, and investigation into other types of experience and 
how they affect OKT is intriguing.  Testing the effects of many different 
experiences will provide greater information about changes in the brain in 
response to experience.  The experiences used here were purposely very specific, 
so that their effects could be directly attributed to visual development, or motor 
learning.  However, investigation of the effects of different experiences may be 
warranted.  Recent research has shown that less specific experiences, such as 
enriched housing and open field testing, do not effect OKT thresholds (Prusky et 
al., in press), and are therefore unlikely to show similar effects to those found in 
the above studies following stroke.  Enriched housing and the open field task may 
have different effects on stroke outcome because they involve input to all the 
senses.  The fact that it may be only specific experiences that affect OKT will 
make characterization of the effects of experience much more feasible and useful.  
Also, characterization of the effects of many different specific experiences and 
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tests which are commonly used in animal models may provide a guideline for the 
amount of plastic change occurring in the brain, and exactly where these change 
are occurring.   
 In these experiments, all animals’ OKT thresholds reduced to very similar 
levels, between 0.50 and 0.52 c/d.  This finding may be evidence of a “floor 
effect”, or the possibility of such an effect may be an overgeneralization, since 
variability in OKT in rodents is extremely low.  Examining other forms of 
experience may continue this pattern, or may also show that this effect is apparent 
only for the experiences chosen here.  The possibility of a floor effect, and the 
reasons for such an effect, should be considered in future research within this 
area.      
An attempt to find motor areas, not affected by MCAo damage, which 
may be associated with the OKT and reach training enhancement is also 
necessary.  The above studies used MCAo to induce damage, and may have 
spared some or all of the dorsal pathway to area MT, a region known to be 
involved in motion perception (Kandel, Schwartz, & Jessel, 2000).  Should the 
reach training enhancement remain untouched after specific motor cortex damage, 
the assumption can be made with certainty that motor areas of the cortex are not 
involved in the enhancement, directly or indirectly, and that the enhancement may 
be related only to the visual cortex.  One could also induce this damage prior to 
experience to note whether motor areas are necessary for he initial induction of 
enhancement.  However, before completely disregarding the inclusion of motor 
areas, subcortical motor damage must also be investigated.  Because OKT is a 
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universal response in vertebrates, it may involve brain centers much lower than 
the cortex.  A pilot study was conducted which induced striatal damage via 
endothelin-1 injection or electrolytic lesion, and found no effect on OKT in 
normal or experienced rats.  This further complicates the issue, but may be 
indicative of a very specific region of involvement in subcortical structures.  Also, 
the striatal damage study was only a pilot study, and a greater number of subjects 
would be necessary to make definitive conclusions.  A final region of the brain 
that may be involved in OKT behaviour is the thalamus.  Visual information 
travels from the retina to the thalamus, before heading on to the visual cortex 
(Kandel, Schwartz, & Jessel, 2000).  Therefore, it is likely that thalamic damage 
would interrupt OKT.  Investigation of this hypothesis could reveal the beginning 
of the pathway involved in OKT.  That is, if thalamic damage does not affect 
OKT, we can conclude that other pathways which stem directly from the retina to 
other areas are the source of the production of OKT, as has been proposed 
previously (Douglas et al., 2005).   
Finally, results presented in Chapter 4 suggest that within V1, there may 
be specific regions associated with certain portions of the visual field.  Animals 
with combined developmental and adulthood experience showed an enhancement 
of OKT thresholds in the monocular visual field, which was also removed with 
V1 cortical damage.  Therefore, there may be separate regions within V1 
responsible for the full visual field effects, and another for monocular field 
effects.  Smaller, more focal lesions in area V1 of animals with combined 
experience, may allow for the 1% monocular, adult experience-induced 
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enhancement to be eliminated, while sparing the 59% developmental full filed 
enhancement, or vice versa.  Further examination of focal V1 lesions hold 
promise for finding separate and specific plasticity pools within this region. 
5.3  Implications for Human Stroke 
 The experiments in this thesis are exciting in that they show that 
experience can affect both normal function and the outcome following stroke.  
However, there are many questions that must be answered for this information to 
be utilized in a clinical setting.  First, do these results transfer to humans?  
Secondly, can human experience be analyzed in a similar way?  That is, because 
humans have a much greater repertoire of life experiences, is it possible to break 
these experiences down to examine the effects of each specifically?  If this is not 
possible, can the effects of combinations of specific experiences be determined?  
Thirdly, can research in this area be used to aid in the application of treatment or 
therapy for stroke patients?   
 As has been mentioned earlier, the test of OKT can be altered for use with 
humans.  It is therefore relatively easy to test for similar effects of experience in 
humans.  Though human experience is far more advanced than laboratory rodents, 
researchers could, for example, test humans with similar specific experiences to 
check for similarities in OKT.  Another possibility would be to test OKT, then 
train humans on a new task and look at OKT again to examine the effects of these 
new experiences on original function.  Similar to the experiments completed here, 
combinations of experience can also be investigated.  Determining the effects of 
both specific and general experiences in humans may be useful in limiting 
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variability in treatment trials as well, as prior experience may be another factor 
which can be controlled for in participant inclusion criteria.     
The information gained from these experiments may be useful in 
analyzing human stroke.  Results showed that plasticity in response to experience 
may be limited.  In Chapter 4 developmental experience caused a significant 
increase in full field OKT thresholds, yet additional experience in adulthood was 
unable to enhance full field OKT further.  The enhancement caused by adulthood 
experience was relocated, and its manifestation changed from a full field 
enhancement of 11%, to a 1% monocular field enhancement.  This suggests that 
there is a limited amount of plasticity available in full field representations within 
V1, and that further experience needs to relocate and change itself in order to 
affect the brain.  Though the plastic capabilities of the human brain are huge (just 
think about all the experiences that a human is involved in throughout their 
lifetime), these data suggest that there may actually be limitations in the amount 
of plasticity that can occur in certain brain regions, or that can be utilized by 
certain therapies.   
If plasticity in humans can be tested, using OKT or any other method, 
recovery may be able to take advantage of brain regions which have greater 
amounts of available plasticity.  That is, for recovery from brain damage, 
researchers and clinicians may be able to draw on areas thought to have a greater 
capacity to accept plastic changes.  This is exciting, as treatment may be directed 
to regions of the brain that will more readily accept plastic changes, as opposed to 
trying to force plasticity in areas that may have little opportunity for change.   
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 Overall, this thesis provides evidence to show that variability in stroke 
outcome is linked to the experiences an individual has throughout life, and that 
different experiences lead to differences in normal function and in functional 
outcomes after stroke.  Also, the VOS test of OKT has proven to be a good animal 
model for testing the effects of experience on the brain.  It is also sensitive to the 
effects of experience on, at the very least, visual cortex stroke outcome.  This 
model also holds promise as a test that can be used in human stroke patients, as 
not only is the function being tested the same in all vertebrate species, but 
technology is now available which will allow for this test to be converted into a 
test for humans.   
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Figures 
Figure 1.  Virtual Optokinetic System (VOS) as shown in Douglas et al., 
2005. A.  A 3D side view cutaway of the VOS.  The center platform, where 
the untrained animal is placed for testing, is surrounded by four LCD 
computer monitors which project the stimulus (sine wave grating).  B.  A 
virtual representation of a rotating cylinder centered on the animal.  
(permission obtained from Dr. Glen Prusky).   
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Figure 2.  Representation of full, monocular, and binocular visual fields 
from the animal’s point of view. 
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Figure 3.  Typical cortical damage induced by MCAo and V1 
devascularization. 
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Figure 4.  Representation of lesion boundaries in normal animals with 
typical laboratory experience; MCAo andV1 devascularization.  Traces of 
lesions superimposed on a brain outline averaged from this group.  Solid 
lines represent MCAo, dashed lines represent V1 damage.  Arrows show 
direction of rotation; tracking occurs only in the naso-temporal direction, 
and therefore clockwise rotation (CW) tests the right hemisphere through 
the left eye, and counterclockwise (CCW) rotation tests the left 
hemisphere through the right eye.  Thick black lines delineate V1 (Paxinos 
& Watson, 1998).  Contralateral and ipsilateral, from here on, are tested 
through the eye opposite the first unilateral V1 lesion.  
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Figure 5.  Full visual field (360°) SF thresholds obtained through each eye 
in normal animals with typical laboratory experience.  Contralateral and 
ipsilateral represent thresholds obtained through the eye contralateral or 
ipsilateral to unilateral V1 lesion, respectively.  Asterisks represent 
significance (*) = p < 0.05, (**) = p < 0.001, (***) = p < 0.0001. 
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Figure 6.  Monocular visual field (115º) spatial frequency (SF) thresholds 
obtained through each eye in normal animals with typical laboratory 
experience.  Contralateral and ipsilateral represent thresholds obtained 
through the eye contralateral or ipsilateral to unilateral V1 lesion, 
respectively.  Asterisks represent significance (*) = p < 0.05, (**) = p < 
0.001, (***) = p < 0.0001. 
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Figure 7.  Average spatial frequency thresholds obtained through both 
eyes each day during P15-P30 developmental visual experience.  
 88
  
Figure 8. Representation of lesion boundaries in animals with 
developmental visual experience; MCAo followed by sequential V1 
devascularizations.  Traces of lesions superimposed on a brain outline 
averaged from this group.  Individual animals’ lesions match in colour.  
Thick black lines delineate V1 (Paxinos & Watson, 1998).  Solid lines 
represent MCAo lesion boundaries, dashed lines represent V1 lesion 
boundaries. 
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Figure 9.  Full visual field (360º) spatial frequency (SF) thresholds 
obtained through each eye in animals with developmental visual 
experience.  Contralateral and ipsilateral represent thresholds obtained 
through the eye contralateral or ipsilateral to unilateral V1 lesion, 
respectively.  Asterisks represent significance (*) = p < 0.05, (**) = p < 
0.001, (***) = p < 0.0001. 
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Figure 10.  Monocular visual field (115º) spatial frequency (SF) thresholds 
obtained through each eye in animals with animals with developmental 
visual experience.  Contralateral and ipsilateral represent thresholds 
obtained through the eye contralateral or ipsilateral to unilateral V1 lesion, 
respectively.  Asterisks represent significance (*) = p < 0.05, (**) = p < 
0.001, (***) = p < 0.0001. 
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Figure 11.  Full visual field (360°) spatial frequency thresholds obtained 
through each eye in animals with developmental visual experience and 
control animals without experience.  Contralateral and ipsilateral represent 
thresholds obtained through the eye contralateral or ipsilateral to unilateral 
V1 lesion, respectively.  Asterisks represent significance (*) = p < 0.05, (**) 
= p < 0.001, (***) = p < 0.0001. 
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Figure 12.  Representation of lesion boundaries in animals with 
developmental visual experience; sequential V1 devascularizations.  
Traces of lesions superimposed on a brain outline averaged from this 
group.  Thick black lines delineate V1 (Paxinos & Watson, 1998).  
Individual animals’ lesions match in colour. 
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Figure 13. Full visual field (360º) spatial frequency thresholds obtained 
through each eye in animals with developmental visual experience; 
sequential V1 devasularizations.  Contralateral and ipsilateral represent 
thresholds obtained through the eye contralateral or ipsilateral to unilateral 
V1 lesion, respectively.  Asterisks represent significance (*) = p < 0.05, (**) 
= p < 0.001, (***) = p < 0.0001. 
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Figure 14.  Monocular visual field (115º) spatial frequency thresholds 
obtained through each eye in animals with developmental visual 
experience; sequential V1 devasculariazation.  Contralateral and 
ipsilateral represent thresholds obtained through the eye contralateral or 
ipsilateral to unilateral V1 lesion, respectively.  Asterisks represent 
significance (*) = p < 0.05, (**) = p < 0.001, (***) = p < 0.0001. 
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Figure 15.  Full visual field (360°) spatial frequency thresholds obtained 
through each eye in animals with developmental visual experience and 
control animals without experience; sequential V1 devascularizations.  
Contralateral and ipsilateral represent thresholds obtained through the eye 
contralateral or ipsilateral to unilateral V1 lesion, respectively.  Asterisks 
represent significance (*) = p < 0.05, (**) = p < 0.001, (***) = p < 0.0001. 
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Figure 16.  Representation of lesion boundaries in animals exposed to 
adulthood motor experience in the form of single pellet reach training; 
MCAo followed by sequential V1 devascularizations.  Traces of lesions 
superimposed on a brain outline averaged from this group.  Individual 
animals’ lesions match in colour.  Thick black lines delineate V1 (Paxinos 
& Watson, 1998).  Solid lines represent MCAo lesion boundaries, dashed 
lines represent V1 lesion boundaries.  Order of lesion induction shown by 
colour.  Dashed line from paw shows crossed nature of motor control, ie. 
left hemisphere controls right side of body and vice versa.  Note that not 
all MCAo lesions were left hemisphere, lesions were grouped on one side 
here to show contralateral to reaching paw. 
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Figure 17. Success in Reaching.  Percent success is represented on y-
axis, days of reaching on x-axis.  Note that reaching success dropped 
following MCAo, and was only briefly affected (approximately one day) by 
V1 lesions.   
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Figure 18.  Full visual field (360º) spatial frequency thresholds obtained 
through each eye in animals with adulthood single pellet reach training 
experience; MCAo and sequential V1 devascularizations.  Contralateral 
and ipsilateral represent thresholds obtained through the eye contralateral 
or ipsilateral to unilateral V1 lesion, respectively.  Asterisks represent 
significance between groups, (*) = p < 0.05, (**) = p < 0.001, (***) = p < 
0.0001. 
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Figure 19.  Monocular visual field (115º) spatial frequency (SF) thresholds 
obtained through each eye in animals with adulthood single pellet reach 
training experience; MCAo and sequential V1 devascularizations.  
Contralateral and ipsilateral represent thresholds obtained through the eye 
contralateral or ipsilateral to unilateral V1 lesion, respectively.  Asterisks 
represent significance between groups, (*) = p < 0.05, (**) = p < 0.001, 
(***) = p < 0.0001. 
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Figure 20.  Full visual field (360°) spatial frequency thresholds obtained 
through each eye for experimental animals with adulthood single pellet 
reach training experience and control animals without experience.  
Contralateral and ipsilateral represent thresholds obtained through the eye 
contralateral or ipsilateral to unilateral V1 lesion, respectively.  Asterisks 
represent significance between groups, (*) = p < 0.05, (**) = p < 0.001, 
(***) = p < 0.0001. 
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Figure 21.  Representation of lesion boundaries in animals exposed to 
adulthood motor experience in the form of single pellet each training, with 
sequential V1 devascularizations.  Traces of lesions superimposed on a 
brain outline averaged from this group.  Individual animals’ lesions match 
in colour. Thick black lines delineate V1 (Paxinos & Watson, 1998).  
Individual animals’ lesions match in colour.   Solid line from paw shows 
crossed nature of motor control, ie. left hemisphere controls right side of 
body and vice versa.   
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Figure 22.  Full visual field (360º) spatial frequency thresholds obtained 
through each eye in animals with adulthood single pellet reach training 
experience; sequential V1 devascularizations.  Contralateral and 
ipsilateral represent thresholds obtained through the eye contralateral or 
ipsilateral to unilateral V1 lesion, respectively.  Asterisks represent 
significance between groups, (*) = p < 0.05, (**) = p < 0.001, (***) = p < 
0.0001. 
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 Figure 23.  Monocular visual field (145º) spatial frequency thresholds 
obtained through each eye for single pellet reach training enhanced 
animals.  Contralateral and ipsilateral represent thresholds obtained 
through the eye contralateral or ipsilateral to unilateral V1 lesion, 
respectively.  Asterisks represent significance between groups, (*) = p < 
0.05, (**) = p < 0.001, (***) = p < 0.0001. 
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 Figure 24.  Full visual field (360°) spatial frequency thresholds obtained 
through each eye in animals with adulthood single pellet reach training 
experience and control animals without experience.  Contralateral and 
ipsilateral represent thresholds obtained through the eye contralateral or 
ipsilateral to unilateral V1 lesion, respectively.  Asterisks represent 
significance between groups, (*) = p < 0.05, (**) = p < 0.001, (***) = p < 
0.0001. 
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Figure 25.  Representation of lesion boundaries in animals exposed to 
both developmental visual experience in the form of OKT testing and 
adulthood motor experience in the form of single pellet each training; 
sequential V1 devascularizations.  Traces of lesions superimposed on a 
brain outline averaged from this group.  Individual animals’ lesions match 
in colour.  Individual animals’ lesions match in colour. Thick black lines 
delineate V1 (Paxinos & Watson, 1998).  Individual animals’ lesions match 
in colour.    
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Figure 26.  Full visual field spatial frequency thresholds obtained through 
each eye in animals with both developmental and adulthood experience.  
Contralateral and ipsilateral represent thresholds obtained through the eye 
contralateral or ipsilateral to unilateral V1 lesion, respectively.  Asterisks 
represent significance (*) = p < 0.05, (**) = p < 0.001, (***) = p < 0.0001. 
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Figure 27.  Monocular visual field (115º) spatial frequency thresholds 
obtained through each eye in animals with both developmental and 
adulthood experience.  Contralateral and ipsilateral represent thresholds 
obtained through the eye contralateral or ipsilateral to unilateral V1 lesion, 
respectively.  Asterisks represent significance (*) = p < 0.05, (**) = p < 
0.001, (***) = p < 0.0001. 
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Figure 28.  Full visual field spatial frequency thresholds obtained through 
each eye in animals with developmental and adulthood experience, and 
control animals without experience.  Contralateral and ipsilateral represent 
thresholds obtained through the eye contralateral or ipsilateral to unilateral 
V1 lesion, respectively.  Asterisks represent significance (*) = p < 0.05, (**) 
= p < 0.001, (***) = p < 0.0001. 
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Appendix A 
 
Tray Reach Experience 
  
 
 
Full visual field (360˚) spatial frequency thresholds for each eye in adult 
animals with tray reach experience.  Contrlateral and ipsilateral to 
unilateral V1 lesion.  (c/d) = Cycles per degree.  Astericks represent 
significance (*) = p < 0.05, (**) = p < 0.001, (***) = p < 0.0001.  Tray reach 
experience enhanced OKT thresholds by 12%.  Overall reduction in OKT 
thresholds following V1 lesions was 14%, similar to single pellet reach 
trained animals. 
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Monocular visual field (145º) spatial frequency thresholds for each eye of 
animals with tray reaching experience.  Contralateral and ipsilateral to 
unilateral V1 lesion.  Asterisks represent significance (*) = p < 0.05, (**) = 
p < 0.001, (***) = p < 0.0001.  Tray reach experience enhanced monocular 
OKT thresholds significantly by 1%.  Overall reduction in OKT thresholds 
following experience and stroke were not different. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Appendix B 
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Contrast Sensitivity Data 
 
A. 
 
 
 
B. 
 
 
A.  Full visual field contrast sensitivity curve for normal animals.  Note 
there were slight differences in contrast curve, which did not match SF 
threshold data (see text for SF thresholds).  B.  Monocular visual field 
contrast curve.   
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B.
  
 
 
A.  Full visual field contrast sensitivity curve of animals with developmental 
visual experience; both MCAo and sequential V1 lesions.  B.  Monocular 
visual field contrast sensitivity curve. 
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B.
 
 
 
A.  Full visual field contrast sensitivity curve of animals with developmental 
visual experience; sequential V1 lesions.  B.  Monocular visual field 
contrast sensitivity curve. 
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B. 
 
 
 
A.  Full visual field contrast sensitivity curve of animals with adulthood 
single pellet reach training experience; both MCAo and sequential V1 
lesions.  B. Monocular visual field contrast sensitivity curve. 
 
A. 
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B.
 
 
 
A.  Full visual field contrast sensitivity curve of animals with adulthood 
single pellet reach training experience; sequential V1 lesions.  B. 
Monocular visual field contrast sensitivity curve. 
 
A.  
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B.
 
 
 
A. Full visual field contrast sensitivity curve of animals with both 
developmental visual experience and adulthood single pellet reach 
training experience; sequential V1 lesions.  B.  Monocular visual field 
contrast sensitivity curve. 
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